equity research: buy case on ubs; hold cs

Upload: cormacleech

Post on 04-Apr-2018

225 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/30/2019 Equity Research: BUY case on UBS; HOLD CS

    1/47

    This document is a marketing communication and is not independent research prepared in accordance with legal requirements

    designed to promote the independence of investment research and is not subject to a prohibition on dealing ahead of the

    dissemination of investment research.

    For Reg-AC certification, see the end of the text. Liberum Capital does and seeks to do business with companies covered in this

    communication. As a result, investors should be aware that the firm may have a conflict of interest that could affect the objectivity of

    this report. Investors should consider this report as only a single factor in making their investment decision.

    10 January 2013 European Equity Research

    Road to Damascus: Long Paul vs. SaulSwiss Banks: BUY UBS; HOLD Credit Suisse

    EUROPE | BANKS | UBSN VX | CSGN VX

    We believe that UBSs decision to radically shrink the capital consumption of its value-destructive IB

    division by a further 57%, and cut IB headcount by some 7,000 will more than double the Groups cap-

    adjusted Return on Basel 3 Equity (RoB3E) from 11.2% in 2012 to 26.0% in 2015. With the capital released

    we expect dividends of at least CHF1.10 by 2015 implying a sustainable yield of 7.4% with special

    dividends taking the 2015-17e average yield to 11.9%. We believe that the effect of all this remains

    markedly underappreciated by the market. BUY with a price target of CHF18. By contrast, CS remains

    committed to its low-RoE IB division which by 2015 we estimate will still consume c60% of group capitalwhilst earning returns of just 5.2% - well below the cost of equity. An ongoing risk of cross-division

    subsidisation will depress the rating. On this basis we believe that CS trades at around fair value. HOLD

    but watch for any hint of shrinking and capital rationing at the IB, in which case there is the possibility of

    an immediate 8-15% upside.

    Dramatic cost reduction for UBS, less so at CS: By 2015e we expect UBS will have cut operating expensesby CHF3bn (13%) via a 15% reduction in headcount. CS will have reduced costs by a more mundane 4%,

    CHF0.9bn, with a 4% decline in head count.

    Rapidly improving capital positions for both UBS and CS: By YE14e UBS will have a Basel 3 core equitytier 1 of 13.6% (vs 3Q12: 9.3%), well in excess of its self imposed capital target. CS will have reached a less

    impressive 11.0% (3Q12: 7.5%), but ahead of fully implemented regulatory requirements.

    Stable/falling RWAs by 2014/15 imply both UBS and CS will be strongly cash generative: By YE 15e UBSwill achieve returns of 26% (capital & regulation adj.) on RWAs of CHF200bn. Declining RWAs and improving

    capital ratios can allow for significant distributions eg. A potential dividend of CHF1.75 in 2015 (11.7% yield).

    Similar logic implies a 7.7% yield for CS (although it is likely to deploy much of this cash in its IB in our view).

    UBS has CHF24.6bn of unrecognised potential deferred tax assets (UPDTAs) due to historic losses. Weestimate an NPV for these of CHF 7.5bn (13% mkt cap, or CHF2.0/share) which bolsters our valuation case.

    Valuation: We use a SoTPs valuation approach taking account of UBSs superior capital position and UPDTAsas well as the higher regulatory drag CS is likely to experience from coming regulatory changes. For a variety of

    reasons we apply a higher multiple to UBS WM business. We suggest 18% relative upside for UBS vs. CS.

    Cormac Leech

    +44 (0)20 3100 [email protected]

    Figure 1: Summary valuation and recommendations

    Target price & ratings 1) Underlyi ng 2013E 2) U/L Reg&Cap adjust ed 2013E4

    Rec PriceTarget

    Price % Upside EPS PEx TCE1 p/TCE RoTCEDiv

    Yld6Cap

    surplus2Cap surp3

    %mkt cap EPS PEx5CoreTCE p/TCE5 RoTCE

    UBS CHF Buy 14.3 18.0 20% 1.22 12.3 12.0 1.2 10.9% 1.3% 2.5bn 4% 1.34 10.0 10.1 1.2 13.2%

    CS CHF Hold 24.4 25.0 2% 2.40 10.2 22.3 1.1 11.0% 3.1% 0.5bn 2% 2.28 10.4 22.2 1.2 10.3%

    Avg 11% 11.2 1.2 10.9% 2.2% 3% 10.2 1.2 11.7%

    1. TCE=Tangible Common Equity per share ; 2. Surplus = equity capital surplus under fully loaded Basel III vs. 10% target; 3. surplus as % of market cap ; 4. 2013E Reg&CapAdjnumbers are ex 1-offs, ex UBS legacy assets, and after buying back shares to eliminate capital surplus ; 5. ratios calculated after deducting 2012-13E announced dividends, UBS

    UPDTAs & value of capital allocated against legacy assets to increase comparability. 6. 2013e div yield. Share price data COB 7th January 2013. Source: Liberum Capital, Bloomberg

  • 7/30/2019 Equity Research: BUY case on UBS; HOLD CS

    2/47

    10 January 2013 Road to Damascus: Long Paul vs. Saul

    2 www.liberumcapital.com

    Contents

    UBS 22

    Credit Suisse 33

    Appendix 44

  • 7/30/2019 Equity Research: BUY case on UBS; HOLD CS

    3/47

    10 January 2013 Road to Damascus: Long Paul vs. Saul

    www.liberumcapital.com 3

    Road to Damascus: Long Paul vs.SaulWe Swiss are farmers, not hunter-gatherers. The asset management business suits ourcharacter as well as our historical position. Your investment banking business, though, has

    never made a penny for your shareholders...1, Swiss National Bank to UBS Chairman in

    2010

    Both UBS and CS are reducing costs to address a weaker revenue

    environment. However UBS plans a considerably more aggressive 57%

    shrinkage in IB RWAs, vs 3Q12 level, via radical restructuring. By contrast CS

    still maintains committed to its IB division which will consume 63% of Group

    Capital by YE15e while generating returns on Basel 3 equity of only 5.2% (post

    Basel 3/ Dodd Frank/cost savings). As a result by 2015, UBS will have a capital

    and regulation adjusted RoB3E of 26.0% vs. only 13.3% for CS a divergencenot yet fully discounted in our view. Over time we expect UBS share price

    outperformance may encourage CS to follow suit boosting fair value by 8-16%

    UBS and CS face a sluggish revenue environment. We estimate by 2015 revenues

    will be c 13-15% below 2010 levels. However both UBS and CS have credible plans

    to reduce costs (figure 15) to counter subdued revenue outlook. We estimate cost

    income ratios for both banks of 72-74% by 2015e from 2012e levels of 78-81%.

    Figure 2: Summary underlying P&L excluding 1-offs*

    % Ch

    CHF bn 2010 2011 2012e 2013e 2014e 2015e 2011 2012e 2013e 2014e 2015e 2015/2010

    Revenues

    UBS 31.1 27.9 27.9 27.5 27.4 27.0 -10% 0% -1% 0% -1% -13%

    CS 30.4 24.4 25.7 25.6 25.5 25.9 -20% 5% 0% 0% 2% -15%

    Costs

    UBS -23.9 -22.0 -22.5 -21.2 -20.3 -19.5 -8% 2% -6% -4% -4% -18%

    CS -23.3 -21.2 -20.0 -19.6 -19.2 -19.2 -9% -5% -2% -2% 0% -18%

    Cost change

    UBS 1.9 -0.5 1.3 0.9 0.8

    CS 2.1 1.1 0.4 0.4 0.0

    Revenue adj, cost change

    UBS -0.5 -0.5 1.1 0.8 0.5

    CS -2.4 2.1 0.3 0.4 0.3

    Cost Income

    UBS 77% 79% 81% 77% 74% 72% 2% 2% 2% -4% -3% -5%

    CS 77% 87% 78% 77% 75% 74% 10% 10% -9% -1% -1% -3%

    PBTUBS 7.1 5.8 5.2 6.3 7.0 7.4 -18% -10% 20% 13% 5% 4%

    CS 7.2 3.1 5.5 5.7 6.1 6.5 -57% 80% 4% 6% 7% -10%

    *Excluding UBS STAB option volatility, business realignment costs, exception litigation, 1-off rebound gains, gains on disposals and other 1-offsSource: Company Reports; Liberum Capital

    UBS: 13% PBT CAGR 2013-15e: On a summary divisional basis UBS we expect

    the asset and wealth management business to grow at an average 11-17% over

    2013-15e resulting in average underlying PBT growth for UBS of 13% despite only

    modest PBT growth in the IB due to exiting of certain FICC business. For full UBS

    divisional P&Ls, excluding 1-off items, see figures 36-43.

    1h t t p : / / t i ny u r l . com / a thw 8 tm , Martin Taylor (former Barclays CEO) FT op-ed 2Nov2012.

  • 7/30/2019 Equity Research: BUY case on UBS; HOLD CS

    4/47

    10 January 2013 Road to Damascus: Long Paul vs. Saul

    4 www.liberumcapital.com

    Figure 3: UBS summary underlying divisional P&L

    CHF bn 2010 2011 2012e 2013e 2014e 2015e 2016e 2017e 2011 2012 2013 2014 2015 2016 2017

    Wealth Mgmt 2.4 2.3 2.3 2.8 3.0 3.1 3.3 3.5 -3% -2% 22% 8% 5% 6% 6%

    Retail & Corporate 1.8 1.7 1.6 1.8 1.8 1.8 1.8 1.7 -6% -3% 12% 0% -1% 0% -3%

    Global Asset Management 0.5 0.5 0.5 0.6 0.7 0.7 0.8 0.8 -12% 11% 24% 11% 6% 4% 4%

    Investment Bank 2.2 1.1 0.9 0.8 1.0 1.0 1.0 1.1 -49% -15% -15% 29% 0% 1% 1%Wealth Management USA 0.3 0.5 0.8 1.1 1.3 1.3 1.4 1.5 86% 75% 32% 14% 6% 6% 3%

    Centre Core 0.0 -0.2 -0.9 -0.8 -0.7 -0.6 -0.5 -0.5 -12% -15% -17% -11% -11%

    Total Underlying PBT ex legacy 7.1 5.8 5.2 6.3 7.0 7.4 7.8 8.1 -19% -10% 20% 13% 5% 5% 4%

    Centre- Legacy 0.0 0.0 0.0 -3.5 -3.5 -1.0 0.0 0.0

    U/L PBT including legacy 7.1 5.8 5.2 2.8 3.5 6.4 7.8 8.1 -19% -10% -47% 29% 81% 21% 4%

    1-offs 0.3 -0.4 -7.5 0.0 0.0 0.0 0.0 0.0

    Reported PBT 7.4 5.4 -2.3 2.8 3.5 6.4 7.8 8.1

    Group MI s -0.3 -0.3 -0.3 -0.3 -0.3 -0.3 -0.3 -0.3

    U/L Attributable 5.3 4.2 3.8 4.6 5.2 5.5 5.8 6.0 -19% -11% 22% 13% 5% 5% 4%

    U/L EPS 1.4 1.1 1.0 1.2 1.4 1.5 1.5 1.6 -19% -11% 23% 13% 5% 5% 4%

    Basel 3 RWAs 380 380 266 226 211 200 192 195

    RoTCE at 10% CT1* 13.8% 11.2% 11.7% 18.8% 24.0% 26.9% 29.6% 31.2%

    *not adjusted for financial regulation (e.g. Dodd Frank, ring-fencing etc)Source: Company Reports; Liberum Capital

    CS: 5% PBT CAGR 2013-15e: Similarly for CS in the asset and wealth

    management divisions we forecast average 2013-15 annual PBT growth of 9-26%

    resulting in group PBT growth of 5% despite flat PBT in the IB (due to sluggish FICC

    revenues). For full divisional P&L, ex 1-off items, see figures 51-57.

    Figure 4: CS summary underlying divisional P&L

    2010 2011 2012e 2013e 2014e 2015e 2011 2012e 2013e 2014e 2015e

    Wealth Mgmt 2.5 1.9 2.2 2.5 2.7 2.9 -26% 19% 9% 9% 9%

    Corporate & Institutional 0.9 0.9 0.9 0.9 0.9 0.9 -2% 3% 0% 0% 3%

    Investment Bank 3.6 0.1 2.7 2.6 2.6 2.6 nm nm -3% 0% 2%

    Asset Management 0.5 0.6 0.3 0.5 0.6 0.6 18% -43% 47% 23% 9%

    Corporate Centre -0.3 -0.3 -0.6 -0.7 -0.7 -0.6 19% 92% 14% 0% -8%

    U/L Total PBT 7.2 3.1 5.5 5.7 6.1 6.5 -57% 80% 4% 6% 7%Rev 1-offs 0.2 1.0 -1.8

    Cost 1-offs -0.6 -1.3 -0.8 -0.5 -0.3 -0.3

    1-offs -0.4 -0.3 -2.6 -0.5 -0.3 -0.3

    Reported Total PBT 6.8 2.7 3.0 5.2 5.8 6.3

    Reported total check 6.8 2.7 3.0 5.2 5.8 6.3

    U/L PAT 5.6 2.3 4.5 4.4 4.7 5.0

    U/L Attributable 4.9 2.0 3.9 3.8 4.1 4.3

    Basel 3 RWAs 398.7 330.0 298.7 277.4 284.7 295.4

    U/L PBT/Avg RWAs 1.8% 0.8% 1.8% 2.0% 2.2% 2.2%

    Ro B3E @10% CT1* 12.2% 5.6% 12.5% 13.3% 14.4% 15.0%

    *not adjusted for financial regulation

    Source: Company Reports; Liberum Capital

    Below consensus for UBS and CS EPS by 2% and 8% respectively

    For UBS we are on average 2% above consensus EPS and 2% below on revenues.

    For CS we are on average 8% below consensus EPS and 10% below on revenues.

  • 7/30/2019 Equity Research: BUY case on UBS; HOLD CS

    5/47

    10 January 2013 Road to Damascus: Long Paul vs. Saul

    www.liberumcapital.com 5

    Figure 5: Liberum revenue and EPS forecasts vs. Bloomberg consensus

    % Ch

    CHF bn 2011 2012e 2013e 2014e 2015e 2016e 2017e 2012e 2013e 2014e 2015e 2016e 2017e

    UBS

    LC e u/l revenue bn 27.9 27.9 27.5 27.4 27.0 27.8 28.5 0% -1% 0% -1% 3% 3%

    LC e reported revenue 29.8 25.6 27.5 27.4 27.0 27.8 28.5Consensus 25.5 27.3 28.2 28.1 n/a n/a -14% 7% 3% 0%

    LCe/ Consensus 0% 1% -3% -4%

    LC e Adj EPS 0.99 1.22 1.38 1.46 1.53 1.59 -11% 23% 13% 5% 5% 4%

    Consensus 1.03 1.08 1.34 1.61 2.10 n/a -7% 5% 24% 20% 31%

    LCe/ Consensus -4% 13% 3% -9% -27%

    CS

    LC e u/l revenue bn 25.7 25.6 25.5 25.9 5% 0% 0% 2%

    LC e reported revenue 24.0 25.6 25.5 25.9

    Consensus 24.4 27.0 28.4 30.6 -4% 10% 5% 8%

    LCe/ Consensus -2% -5% -10% -15%

    LC e Adj EPS 2.29 2.40 2.54 2.73 86% 5% 6% 8%

    Consensus 1.84 2.51 2.90 2.99 50% 36% 16% 3%LCe/ Consensus 24% -4% -13% -8%

    Source: Company Reports; Liberum Capital

    For UBS sharp rise in RoB3E due to reduced CapitalConsumptionCapital consumption change 2011-15: down 47% for UBS; down 13% for CS

    For Credit Suisse, the reduction in RWAs from YE11-YE15e is likely to be much less

    than for UBS. From YE11-15e, UBS will have reduced its RWAs by 47% to

    CHF200bn vs. a 13% decline for CS to CHF295bn.

    Figure 6: UBS and CS Basel 3 RWAs CHFbn 2010-2017e

    150

    200

    250

    300

    350

    400

    450

    2010 2011 2012e 2013e 2014e 2015e 2016e 2017e

    UBS CS

    Source:

    UBS RWA shrinkage implies a reduction in required capital of CHF18bn by YE15e

    vs. YE11 equivalent (32% of mkt cap) vs. a decline in RWAs of only 14% for Credit

    Suisse (11% of mkt cap).

    UBSs Capital consumption will

    drop by 47% 2011-2015 vs. a drop

    of only 13% for CS

  • 7/30/2019 Equity Research: BUY case on UBS; HOLD CS

    6/47

    10 January 2013 Road to Damascus: Long Paul vs. Saul

    6 www.liberumcapital.com

    2012-15e: UBS RoB3E will more than double; limited improvement for CS

    Despite both banks making significant improvements in attributable income, UBS will

    deliver a stronger increase in Cap&Reg adjusted RoB3E 2012-15e, rising from

    11.2% to 26.0% compared to CSs more subdued rise from 9.8% to 13.3% for CS.

    This divergence explains much of expected TSR outperformance we expect forUBS.

    Figure 7: Change in RWAs and impact on Return on Basel 3 equity at 10% gearing

    2011 2012e 2013e 2014e 2015e

    RWAs Basel 3

    UBS 380 266 226 211 200

    CS 339 299 277 285 295

    Capital requirement at 10%

    UBS 38 27 23 21 20

    CS 34 30 28 28 30

    Cumul. Chnge in Capital requir ed

    UBS (11) (15) (17) (18)

    CS (4) (6) (5) (4)

    Cumulative capital release as % mkt cap

    UBS -20% -27% -30% -32%

    CS -10% -16% -14% -11%

    Attributable Income

    UBS 4.3 3.8 4.6 5.2 5.5

    CS 1.5 3.6 3.8 4.1 4.4

    Return on Basel 3 equit y at 10% gearing to RWAs

    UBS 11.2% 11.7% 18.8% 24.0% 26.9%

    CS 4.0% 11.4% 13.3% 14.4% 15.1%

    Return on Basel 3 equity adjusted for regulation*

    UBS 10.7% 11.2% 18.1% 23.2% 26.0%

    CS 2.7% 9.8% 11.5% 12.6% 13.3%

    *assume minus CHF0.5bn net of tax impact for CS and minus CHF0.2bn impact for UBS due to Dodd Frank and Ring-Fencing etcSource: Liberum Capital

    Comparing Return on Basel 3 equity (RoB3E) is more meaningful than RoTCE

    due to differences in composition of TCE for both banks:

    As figure 8 illustrates due to items such as unrealised losses from cash flow hedges,

    TCE per share is 73% higher than Basel 3 equity regulatory capital for UBS vs. only

    42% for CS which misleadingly depresses UBSs relative RoTCE. Since Basel 3

    equity capital determines capital adequacy, RoB3E is a more meaningful

    For UBS the underlying RoB3E will

    more than double from 2012-

    2015e vs. a much more muted

    32% rise for CS mainly due to

    differences in divergence in capital

    consumption but also due to more

    rapid earnings growth due to

    business mix changes

  • 7/30/2019 Equity Research: BUY case on UBS; HOLD CS

    7/47

    10 January 2013 Road to Damascus: Long Paul vs. Saul

    www.liberumcapital.com 7

    Figure 8: Bridge from TCE to Basel 3 equity capital 3Q12

    B3 equity =

    100% Per Share

    % Basel 3

    RWAs

    CHF bn UBS CS UBS CS UBS CS UBS CS

    Shareholders equity 52.4 35.7 14.0 22.4

    Goodwill -6.6 (8.9) -1.8 -5.6Mandatory convert 0.0 3.6 0.0 2.3

    Tangible Common Equity 45.8 30.4 173% 142% 12.2 19.115.2

    % 9.9%

    Unrealised losses from Cash flow hedges -3.2 -12% 0% -0.9 0.0 -1.1% 0.0%

    Treasury shares -0.7 -3% 0% -0.2 0.0 -0.2% 0.0%

    ex Fair Value Own Debt (FVoD) -0.1 (0.3) -1% -1% 0.0 -0.2 0.0% -0.1%

    Pension plan adjustments 0.0 2.8 0% 13% 0.0 1.8 0.0% 0.9%

    Qualifying non controlling interest 0.0 3.2 0% 15% 0.0 2.0 0.0% 1.1%

    Other Capital deductions (3.7) (1.8) -14% -8% -1.0 -1.1 -1.2% -0.6%

    Basel II core tier 1 38.0 34.4 144% 160% 10.1 21.6

    12.6%

    11.2%

    Ex non controlling interests (3.2) 0% -15% 0.0 -2.0 0.0% -1.1%

    Deferred tax -5.3 (7.2) -20% -34% -1.4 -4.5 -1.8% -2.3%

    Pension -3.8 -14% 0% -1.0 0.0 -1.3% 0.0%

    StabFund Option -1.0 -4% 0% -0.3 0.0 -0.3% 0.0%Net Other deductions 0.0 (1.0) 0% -5% 0.0 -0.6 0.0% -0.3%

    Basel III equity tier 1 co def 28.0 22.9 106% 107% 7.5 14.4 9.3% 7.5%

    Libor rigging litigations/fines (1.5) (1.5) -6% -7% -0.4 -0.9 -0.5% -0.5%

    Basel III equit y tier 1 LCe def 26.5 21.4 100% 100% 7.1 13.5 8.8% 7.0%

    #shares outstanding diluted 3.7 1.6

    Basel 3 RWAs 301 307

    Attributable 2012e 3.8 3.2

    RoTCE 8.3%

    10.7

    %

    Ratio of RoTCE for CS vs. UBS in 2012** 1.3x

    RoB3CT1 14.3% 15.1%

    Ratio of RoB3CT1 for CS vs. UBS in2012** 1.1x

    *Fully loaded; CS returns are higher due to a lower capital ratio.Source: Company accounts; Liberum Capital

    Figures 9 and 10 show our forecasted returns for UBS and CS on an i) underlying

    basis ii) After assuming a buyback/ special dividend to eliminate excess capital iii)

    After also adjusting for the earnings drag from more onerous regulation: By 2015 on

    a FinReg and Cap adjusted basis we expect UBS and CS to achieve a RoB3E

    of 26.0% and 13.3% respectively which is the most meaningful valuation

    metric in our view

    Figure 9: UBS underlying return on Basel 3 equity Figure 10: CS underlying return on Basel 3 equity

    0%

    5%

    10%

    15%

    20%

    25%

    30%

    2011 2012 2013 2014 2015

    UBS underly ing UBS Cap Adj UBS FinReg Cap Adj

    0%

    5%

    10%

    15%

    20%

    25%

    30%

    2011 2012 2013 2014 2015

    CS under ly ing CS Cap Adj CS F inReg Cap Adj

    *FinReg: Financial Regulation such as Dodd Frank and Ring FencngSource: Liberum Capital

    *FinReg: Financial Regulation such as Dodd Frank and Ring FencngSource: Liberum Capital

    Analysis of composition of TCE

    shows that a relatively large

    proportion of UBSs tangible book

    value is not eligible Basel 3 equity

    capital which tends to misleadingly

    understate relative returns on

    equity vs. CS.

  • 7/30/2019 Equity Research: BUY case on UBS; HOLD CS

    8/47

    10 January 2013 Road to Damascus: Long Paul vs. Saul

    8 www.liberumcapital.com

    UBS could annually yield 11.9% 2015-17e; CS 8.6%UBS has scope to pay significant dividends: 9.5% by 2015e (7.4% sustainable)

    Our base case forecasts UBS will pay a cash dividend equivalent to a 3.3% yieldin 2014, rising to a 9.5% in 2015-2017e. Despite this substantial yield, the Basel

    3 core tier 1 continues to climb reaching 15.8% in 2017e.

    Alternatively solving for a steady 13.6% Basel 3 equity ratio (the YE13e level)implies an average annual 11.9% yield over 2015-17.

    The maximum sustainable underlying yield over the same period assuming 5%annual growth would be 7.9% (assuming 5% normalised RWA growth) implying a

    4% annual special dividend from 2015-17e (i.e. 7.9%+4.0%=11.9%) as the

    business transitions.

    Put differently from YE14-YE17e, UBS will generate distributable cash ofCHF20.3bn after which a sustainable c8.4% dividend (from 2018e) looks feasible

    equivalent to a payout ratio of c 80% growing broadly in line with invested assets,

    with improving operating leverage roughly offsetting likely margin pressure.

    Limiting the UBS capital ratio to

    13.6% implies a 11.9% yield 2015-

    17e of which 7.9% is sustainable

    and 4% special

  • 7/30/2019 Equity Research: BUY case on UBS; HOLD CS

    9/47

    10 January 2013 Road to Damascus: Long Paul vs. Saul

    www.liberumcapital.com 9

    Figure 11: UBS dividend scenarios: conservative; targeting stable Basel 3 equity 2014-17e; long run sustainable dividend

    CHF bn 2011 2012e 2013e 2014e 2015e 2016e 2017e Avg 2015-17e

    RWAs 380 266 226 211 200 192 195

    Basel 3 equity 25 25 27 29 29 30 31

    Basel 3 equity as % RWAs base case 6.7% 9.3% 11.8% 13.6% 14.2% 15.4% 15.8%

    Statutory Attributable CHF 4.2 -3.1 2.1 2.8 5.2 6.4 6.6

    Underlying Attributable 4.3 3.8 4.6 5.2 5.5 5.8 6.0

    avg #shares bn 3.8 3.8 3.8 3.8 3.796 3.8 3.8

    Adj EPS 1.11 0.99 1.22 1.38 1.46 1.53 1.59

    i) Base case

    Payout ratio statutory 9% -18% 36% 68% 102% 84% 81%

    Payout ratio underlying 9% 15% 16% 36% 96% 91% 88%

    Dividend CHF bn 0.4 0.6 0.7 1.9 5.3 5.3 5.3

    Announced DPS 0.10 0.15 0.20 0.50 1.42 1.42 1.42

    Current share price 15

    Implied yield 0.7% 1.0% 1.3% 3.3% 9.5% 9.5% 9.5% 9.5%

    ii) DIV for unch. Capital fro m 2014Basel 3 equity 25 25 27 29 27 26 25

    Basel 3 equity % 6.7% 9.3% 11.8% 13.6% 13.6% 13.6% 13.0%

    Payout ratio underlying 9.0% 15.1% 16.4% 36.2% 120% 127% 104%

    Dividend CHF bn 0.4 0.6 0.7 4.8 6.6 7.4 6.3

    DPS 0.10 0.15 0.20 0.50 1.75 1.95 1.66

    Implied yield 0.7% 1.0% 1.3% 3.3% 11.7% 13.0% 11.1% 11.9%

    iii) Sustainable Dividend

    Underlying Attributable 4.3 3.8 4.6 5.2 5.5 5.8 6.0

    RWAs 200 192 195

    Assumed RWAs Growth 5% 5% 5%

    RWA Growth CHF bn 10 10 10

    Cap. Consumption @13% 1.3 1.3 1.3

    Implied Payout ratio 76% 78% 79%

    Implied DPS 1.1 1.2 1.3

    Implied Yield 7.4% 8.0% 8.4% 7.9%

    Source: Liberum Capital estimates

    CS base case: cash dividend yield of 4.7% by 2015e

    For CS the capacity to distribute cash is less impressive due to lower returns andless reduction in capital requirements. That said, our base case forecast of

    2015e DPS of CHF 1.15 (underlying payout ratio of 42%) is still equivalent to a

    4.7% yield.

    Alternatively solving for a steady 11.0% Basel 3 equity ratio (the YE13e level)implies an average annual 8.6% yield over 2015-17.

    For CS, we estimate the max sustainable yield to be 6.2% assuming 6% RWAgrowth (higher RWA growth than UBS given higher IB mix).

    For UBS, in our base case despitepaying a dividend of CHF1.42 per

    share from 2015e, yield of 9.5%,

    the Basel 3 equity ratio continues

    to climb to 15.8% by 2017e.

    For UBS, solving for the dividend

    required to keep the equity capital

    ratio fixed at 13.6%, implies a

    dividend of CHF 1.75 in 2015e and

    an average yield 2015-17e of

    11.9%

    Assuming long run RWA growth of

    5% (c NGDP) implies a payout

    ratio of 79%, sustainable long term

    dividend yield of 7.9%, growing at

    perhaps 4-5% per annum

  • 7/30/2019 Equity Research: BUY case on UBS; HOLD CS

    10/47

    10 January 2013 Road to Damascus: Long Paul vs. Saul

    10 www.liberumcapital.com

    Figure 12: CS dividend scenarios: conservative; targeting stable Basel 3 equity 2014-17e; long run sustainable dividend

    CHF bn 2011 2012e 2013e 2014e 2015e 2016e 2017e Avg 2015-17e

    RWAs 339 299 277 285 295 304.3 313.4

    Basel 3 equity 12 24 28 31 34 36.8 39.4

    Basel 3 equity % 3.6% 8.2% 10.2% 11.0% 11.6% 12.1% 12.6%

    Statutory Attributable CHF 1.6 3.1 3.5 3.9 4.2 4.4 4.6

    Underlying Attributable 1.9 3.8 3.8 4.1 4.4 4.4 4.6

    avg #shares bn 1.2 1.6 1.6 1.6 1.6 1.6 1.6

    Adj EPS 1.58 2.37 2.40 2.54 2.73 2.87 3.01

    i) Base case

    Payout ratio statutory 55% 32% 39% 41% 44%

    Payout ratio underlying 48% 26% 35% 39% 42% 43% 43%

    Dividend CHF bn 0.9 1.0 1.4 1.6 1.8 2.0 2.1

    Announced DPS 0.75 0.75 0.85 1.00 1.15 1.23 1.30

    Current share price 24.38

    Implied yield 3.1% 3.1% 3.5% 4.1% 4.7% 5.1% 5.3% 5.0%

    ii) DIV for unch. Capital fro m 2014Basel 3 equity 12 24 28 31 32 33 34

    Basel 3 equity % 3.6% 8.2% 10.2% 11.0% 11.0% 11.0% 11.0%

    Payout ratio underlying 55% 32% 39% 79% 72% 78% 78%

    Dividend CHF bn 0.9 1.0 1.4 3.1 3.0 3.4 3.6

    DPS 0.75 0.75 0.85 1.00 1.88 2.14 2.26

    Implied yield 3.1% 3.1% 3.5% 4.1% 7.7% 8.8% 9.3% 8.6%

    iii) Sustainable Dividend

    Underlying Attributable 1.6 3.1 3.5 3.9 4.2 4.4 4.6

    RWAs 285 295 316.1 338.2

    Assumed RWAs Growth 6% 6% 6% 6%

    RWA Growth CHF bn 17 18 19 20

    Cap. Consumpt ion @11% 1.9 1.9 2.1 2.2

    Implied Payout ratio 51% 53% 52% 52%

    Implied DPS 0.75 0.75 0.85 1.3 1.5 1.5 1.6

    Implied Yield 3.1% 3.1% 3.5% 5.4% 6.0% 6.2% 6.4% 6.2%

    Source: Company Reports; Liberum Capital

    As a summary comparison, Figures 13 and 14 illustrate that UBS is likely to return

    significantly more cash over the next 5 years under the various scenarios.

    Figure 13: UBS dividend yield scenarios Figure 14: CS dividend yield scenarios

    0.0%

    5.0%

    10.0%

    15.0%

    2 01 1 2 012 e 20 13 e 2 014 e 20 15 e 2 016 e 20 17 e

    ba se c ase ma in ta in 1 3.6 % ca pita l s us ta in abl e

    0.0%

    5.0%

    10.0%

    15.0%

    2011 201 2e 20 13e 2 014e 2015e 201 6e 20 17e

    b ase cas e ma intain 11% capital s us tai nabl e

    Source: Liberum Capital Source: Liberum Capital

    Given UBSs significant cash generation, we see downside risk from potentiallyvalue destroying acquisitions. It remains to be seen whether management will

    distribute the maximum appropriate level of capital to shareholders.

    For CS, in our base case despite

    paying a dividend of CHF1.15 per

    share from 2015e, yield of 4.7%,

    the Basel 3 equity ratio continuesto climb to 12.6% by 2017e

    For CS, solving for the dividend to

    keep the Basel 3 capital ratio at

    11.0% in 2015e implies a dividend

    of 1.88, yielding 7.7% and an

    average 2015-17e yield of 8.6%

    Assuming RWA growth of 6%

    implies a payout ratio of 52% and

    a sustainable yield of 6.2%

    growing at perhaps 4%

    UBS: Obvious future risk of

    substantial cash generation

    leading to complacency/ value-

    dilutive M&A; manageable risk in

    our view with the right

    management incentives

  • 7/30/2019 Equity Research: BUY case on UBS; HOLD CS

    11/47

    10 January 2013 Road to Damascus: Long Paul vs. Saul

    www.liberumcapital.com 11

    Both UBS and CS undertaking significant cost saveinitiatives through 2015e likely to significantlyimprove PBT

    UBS cost reduction plan, 2013-2015e Limited efficiency gains in 2012e: On an underlying basis UBS will increase

    costs by CHF0.5bn in 2012 to CHF 22.5bn vs. 2011 adversely impacted by a

    CHF0.6bn adverse FX move.

    Mgmt target CHF4bn of cost saves by 2015e: From the 2012e cost run-rate ofCHF22.5bn, Management have committed to a further CHF4bn reduction by

    2015 to cCHF18.5bn in 2015e, or CHF2.5bn net of CHF1.5bn of investment

    spend.

    We assume reduced investment spend due to weak revenues: Our own

    forecasts assume underlying 2015e costs of 19.5bn (down CHF3.0bn from2012e), CHF0.5bn lower than management guidance in effect we are

    forecasting that management will cut back on investment spend due to a weak

    revenue environment. Our 2015e revenues are CHF1.1bn below consensus and

    our 2015e EPS is conservatively 9% below Bloomberg consensus.

    Our base case forecasts revenue-adjusted cost reduction of CHF2.3bn by2015e after changes in costs are adjusted for changes in revenues assuming a

    marginal 75% cost income ratio vs. the 2012 run-rate.

    Base case forecasted CHF3bn cost reduction looks achievable: equivalentto 13% of cost base and seems feasible given the planned 15% reduction in

    headcount (10,000 staff) and also the IB business exits within credit and rates.

    See figure 24 below for detailed analysis costs per employee by division for UBS.

    CS cost reduction plan, 2013-2015e

    Improved efficiency in 2012e: On an underlying basis CS reduced costs byCHF0.8bn in 2012e to CHF 20.3bn vs. 2011, reducing the clean cost income

    ratio to 78% from the uncomfortably high 87% in 2011.

    Management guide for CHF2bn reduction by 2015 (excluding variablecompensation) vs. 9M12 level. This would imply 2015e costs of c CHF18.3bn.

    Our own forecasts assume underlying 2015e costs of 19.3bn down CHF0.9bn

    from 2012e or CHF1.1bn higher than management guidance as we expectinvestment spend and other factors (such as e.g. regulatory spend, PAF3/ Bond

    Plus etc) to significantly impact costs. As context, our 2015e revenues are

    CHF4.7bn below consensus (admittedly small Bloomberg sample) and our EPS

    is 8% below consensus. Reverse engineering this consensus implies consensus

    2015e group costs of CHF23.2bn and a cost income ratio of 76% vs. our 74%

    implying consensus cost reduction expectations (even revenue adjusted)

    are lower than our own forecasts.

    On a revenue adjusted basis where changes in costs are adjusted for changesin revenues assuming a marginal 75% cost income ratio, we forecast CS will

    eliminate CHF1.0bn in costs by 2015e equivalent to 5% of total costs. This looksfeasible given

    For UBS we assume CHF3bn of

    cost reduction 2015e vs. 2012e

    For CS we assume CHF0.9bn of

    cost reduction by 2015e vs. 2012e.

    Our 2015e CS cost income ratio of

    74% is below an estimated

    Bloomberg consensus 76%

  • 7/30/2019 Equity Research: BUY case on UBS; HOLD CS

    12/47

    10 January 2013 Road to Damascus: Long Paul vs. Saul

    12 www.liberumcapital.com

    opportunities to rationalise FICC, Underwriting and advisory business in

    some geographies

    scope to consolidate back office systems.

    high 2012e starting point cost income ratio of 78%

    progress being made: the CHF1.8bn of cost saving progress achieved in

    2012 also point to further efficiency gains over 2013-2015.

    Figure 15 summaries our cost forecasts for UBS and CS

    Figure 15: Cost reduction plans absolute and revenue adjusted.

    2010 2011 2012 2013 2014 2015 2016 2017 Cumul. FY13-15 inclusive

    Clean Revenues

    UBS 31.1 27.9 27.9 27.5 27.4 27.0 27.8 28.5

    CS 30.4 24.4 25.7 25.6 25.5 25.9Clean Costs

    UBS 23.9 22.0 22.5 21.2 20.3 19.5 19.9 20.4

    CS 23.3 21.2 20.0 19.6 19.2 19.2

    Cost income ratio

    UBS 77% 79% 81% 77% 74% 72% 72% 71%

    CS 77% 87% 78% 77% 75% 74%

    Clean PBT

    UBS 7.1 5.8 5.2 6.3 7.0 7.4 7.8 8.1

    CS 7.2 3.1 5.5 5.7 6.1 6.5

    Change in Clean PBT

    UBS -1.3 -0.6 1.0 0.8 0.4 0.4 0.3 2.2

    CS -4.1 2.5 0.2 0.3 0.4 1.0

    Change in Revenues

    UBS -3.1 -0.1 -0.4 -0.1 -0.4 0.8 0.8 -0.9

    CS -6.0 1.3 -0.1 -0.1 0.4 0.2Change in costs

    UBS -1.9 0.5 -1.3 -0.9 -0.8 0.4 0.5 -3.0

    CS -2.1 -1.1 -0.4 -0.4 0.0 -0.9

    Assumed incremental Cost income ratio

    UBS 75% 75% 75% 75% 75% 75% 75%

    CS 75% 75% 75% 75% 75% 75% 75%

    Cost change due to Revenue Change

    UBS -2.3 -0.1 -0.3 -0.1 -0.3 0.6 0.6 -0.6

    CS -4.5 1.0 -0.1 -0.1 0.3 0.1

    Revenue adjusted cost reduction

    UBS 0.5 0.5 -1.1 -0.8 -0.5 -0.2 -0.1 -2.3

    CS 2.4 -2.1 -0.3 -0.4 -0.3 -1.0

    Source: Company Reports; Liberum Capital

    By YE15e UBS will have only 16% more staff than CS down from 30% currently

    By 2015E UBS plans to have reduced head count by 15% to 54,000 down fromthe 3Q12 level of 63,700 mainly within the IB division where we estimate staff

    reduction from 16,500 to 9,500 by YE15e.

    By contrast Credit Suisse has publicly committed to staff cuts of only 2,000 fromthe 2Q11 levels, which were already largely complete by 3Q12 with a total staff

    level of 48,400.

    We estimate that Credit Suisse will cut a further 2,000 jobs by YE15e implyingtotal headcount of 46,400 (although CS has not given staffing level guidance-

    Taking changes in revenue into

    consideration we are forecasting

    CHF2.3bn of cost reduction forUBS and CHF1.0bn for CS

  • 7/30/2019 Equity Research: BUY case on UBS; HOLD CS

    13/47

    10 January 2013 Road to Damascus: Long Paul vs. Saul

    www.liberumcapital.com 13

    apparently for legal reasons according to IR). We expect 1,500 of these cuts are

    likely to be in the IB division (front and back-office)

    By YE15e UBS will have only 16% more staff than CS down from 63% at YE08

    and 30% at 3Q12e.

    Figure 16: UBS headcount by division Figure 17: CS headcount by division

    0

    20

    40

    60

    80

    2008 2009 2010 2011 2012e 2013e 2014e 2015e

    IB WM WMA R&C/ CIC GAM Centre

    0

    20

    40

    60

    80

    200 8 2009 2010 2011 2012e 2013e 201 4e 20 15e

    IB WM R&C/CIC AM Centre

    Source: Company Reports; Liberum Capital Source: Company Reports; Liberum Capital

    Focusing on the change 2015 vs. 2012 shows a dramatic shrinkage in the IB head

    count for UBS down 42% to 9,500 and down 7% for CS to 19,100.

    Figure 18: UBS headcount changes Figure 19: CS headcount changes

    010

    20

    30

    40

    50

    60

    70

    Group Non IB IB

    2012 2015

    0

    10

    20

    30

    40

    50

    60

    70

    Group Non IB IB

    2012 2015

    Source: Company Reports; Liberum Capital Source: Company Reports; Liberum Capital

    Our divisional cost forecasts imply relatively stable revenues and costs per

    employee

    As the tables below illustrate our forecasts imply a modest 6% uptick in revenues

    per employee in 2015e vs. 2012e, for both UBS and CS to CHF0.57m and 0.55m

    respectively with costs/employee essentially flat at CHF 0.36m and CHF0.41m

    respectively. Staff costs/employee are up modestly (5% for UBS, 1% for CS)

    respectively.

    Figure 20: UBS Group revenue and costper employee , CHF m

    Figure 21: CS Group revenue and costper employee, CHF m

    0.00

    0.10

    0.20

    0.30

    0.40

    0.50

    0.60

    Revenue Cost Staff cost

    2012 2015

    0.00

    0.10

    0.20

    0.30

    0.40

    0.50

    0.60

    Revenue Cost Staff cost

    2012 2015

    Source: Company Reports; Liberum Capital Source: Company Reports; Liberum Capital

    UBSs headcount is trending

    towards that of CS: by 2015e UBS

    will have just 16% more staff down

    from 130% at 3Q12

    UBS will IB staff by 42% by 2015

    vs current levels.

    We expect only 7% cuts for CS

    Our assumed costs per employee

    are relatively stable 2015 vs. 2012

    with most of the savings from

    headcount reduction

  • 7/30/2019 Equity Research: BUY case on UBS; HOLD CS

    14/47

    10 January 2013 Road to Damascus: Long Paul vs. Saul

    14 www.liberumcapital.com

    IB division revenue and costs per FTE are relatively stable

    Looking at the IB divisions in more detail, we expect cost per FTE will decline by 2%

    for UBS to CHF0.47m and decline by 1% for CS to CHF0.51m.

    IB Revenues per FTE are expected to rise by 6% for UBS to CHF0.57m as lessprofitable areas are exited and by 1% for CS to CHF0.65m.

    Figure 22: UBS IB division revenue andcost per employee

    Figure 23: CS IB division revenue andcost per employee

    0.00

    0.10

    0.20

    0.30

    0.40

    0.50

    0.60

    0.70

    Revenue Cost Staff cost

    2012 2015

    0.00

    0.10

    0.20

    0.30

    0.40

    0.50

    0.60

    0.70

    Revenue Cost Staff cost

    2012 2015

    Source: Liberum Capital Source: Liberum Capital

    In 2012 CS IB staff are 20% more

    productive than UBSs in revenue

    terms but also 7% more expensive

    in total cost terms and 4% more

    expensive in terms of average

    compensation

  • 7/30/2019 Equity Research: BUY case on UBS; HOLD CS

    15/47

    10 January 2013 Road to Damascus: Long Paul vs. Saul

    www.liberumcapital.com 15

    For completeness we include the full cost and revenue per FTE table for UBS:

    Figure 24: UBS Divisional costs and revenues per FTE

    Head co unt

    '000s 2010 2011 2012e 2013e 2014e 2015e 2015e/2012

    IB 16.9 17.3 16.5 14.4 12.5 9.5 -42%WM 15.7 15.9 16.3 15.3 15.1 15.6 -5%

    WMA 16.3 16.2 16.2 16.3 16.0 15.2 -6%

    R&C/ CIC 12.1 11.4 10.2 9.6 9.8 9.8 -4%

    GAM 3.5 3.8 3.8 3.6 3.4 3.4 -11%

    Centre 0.2 0.3 0.5 0.5 0.5 0.5 0%

    Total 64.6 64.8 63.6 59.7 57.2 54.0 -15%

    Clean Cost by Division

    CHF bn 2010 2011 2012e 2013e 2014e 2015e 2015e/2012

    WM 5.0 4.9 4.8 4.7 4.8 4.9 1%

    R&C/ CIC 2.1 2.1 2.1 1.9 1.9 1.9 -10%

    GAM 1.5 1.3 1.4 1.3 1.3 1.3 -4%

    IB 9.6 8.7 8.1 7.1 6.2 5.2 -36%

    WMA 5.3 4.7 5.2 5.3 5.4 5.6 7%

    Centre 0.4 0.3 0.8 0.9 0.7 0.6 -24%

    Total 23.9 22.1 22.5 21.2 20.3 19.5 -13%

    Staff cost by division

    CHF bn 2010 2011 2012e 2013e 2014e 2015e 2015e/2012

    WM 3.2 3.3 2.9 2.9 2.9 3.0 6%

    R&C/ CIC 1.6 1.7 1.4 1.3 1.3 1.3 -2%

    GAM 1.1 1.0 0.9 0.9 0.9 0.9 -2%

    IB 6.5 5.6 4.9 4.3 3.8 3.2 -36%

    WMA 4.2 3.8 4.3 4.4 4.5 4.6 7%

    Centre 0.1 0.1 0.3 0.3 0.3 0.3 -10%

    Total 16.8 15.4 14.6 14.1 13.7 13.3 -9%

    Implied loaded Cost per FTE

    CHFm 2010 2011 2012e 2013e 2014e 2015e 2015e/2012

    WM 0.32 0.31 0.30 0.30 0.31 0.32 6%

    R&C/ CIC 0.17 0.18 0.20 0.19 0.20 0.20 0%

    GAM 0.44 0.37 0.36 0.36 0.37 0.39 7%

    IB 0.59 0.51 0.48 0.46 0.46 0.47 -2%

    WMA 0.32 0.29 0.32 0.33 0.34 0.37 14%

    Centre 1.97 0.96 1.48 1.58 1.35 1.13 -24%

    Total 0.37 0.34 0.35 0.36 0.35 0.36 2%

    Implied staff cost per FTE

    CHFm 2010 2011 2012e 2013e 2014e 2015e 2015e/2012

    WM 0.20 0.21 0.18 0.18 0.19 0.20 11%

    R&C/ CIC 0.13 0.14 0.13 0.14 0.14 0.14 9%

    GAM 0.32 0.26 0.24 0.24 0.25 0.26 9%

    IB 0.40 0.33 0.29 0.28 0.28 0.29 -1%

    WMA 0.25 0.24 0.26 0.27 0.28 0.29 11%

    Centre 0.13 0.30 0.72 0.54 0.51 0.49 -32%

    Total 0.26 0.24 0.23 0.23 0.23 0.24 5%

    Revenue by division

    CHF bn 2010 2011 2012e 2013e 2014e 2015e 2015e/2012

    WM 7.4 7.2 7.1 7.4 7.8 8.0 13%

    R&C/ CIC 3.9 3.9 3.7 3.7 3.7 3.7 -1%

    GAM 2.1 1.8 1.9 1.9 2.0 2.0 10%

    IB 11.8 9.8 9.0 7.9 7.2 6.3 -31%

    WMA 5.6 5.2 6.1 6.4 6.7 6.9 14%

    Centre 0.4 0.0 0.0 0.0 0.0 0.0 nm

    Total 31.1 27.9 27.9 27.5 27.4 27.0 -3%

    Implied revenue per FTE

    CHFm 2010 2011 2012e 2013e 2014e 2015e 2015e/2012

    WM 0.47 0.46 0.44 0.47 0.51 0.52 18%

    R&C/ CIC 0.33 0.33 0.35 0.38 0.38 0.38 9%

    GAM 0.59 0.50 0.49 0.53 0.57 0.60 22%

    IB 0.72 0.57 0.54 0.51 0.54 0.57 6%

    WMA 0.33 0.32 0.38 0.40 0.42 0.45 19%

    Centre nm nm nm nm nm nm nmTotal 0.48 0.43 0.43 0.45 0.47 0.49 12%

    Source: Liberum Capital

  • 7/30/2019 Equity Research: BUY case on UBS; HOLD CS

    16/47

    10 January 2013 Road to Damascus: Long Paul vs. Saul

    16 www.liberumcapital.com

    And similarly for CS:

    Figure 25: CS Divisional costs and revenues per FTE

    Head co unt

    '000s 2010 2011 2012e 2013e 2014e 2015e 2015e/2012

    IB 20.7 20.9 20.6 19.6 19.6 19.1 -7%WM 20.5 20.2 19.3 19.3 19.1 19.2 0%

    R&C/CIC 5.1 5.0 4.8 4.9 4.9 4.9 2%

    AM 2.9 2.7 2.8 2.7 2.5 2.3 -18%

    Centre 0.9 0.9 0.9 0.9 0.9 0.9 0%

    Total 50.1 49.7 48.4 47.4 47.1 46.4 -4%

    129% 130% 131% 126% 122% 116%

    Clean Cost by Division

    CHF bn 2010 2011 2012e 2013e 2014e 2015e 2015e/2012

    WM 7.2 7.0 6.2 6.2 6.2 6.2 -1%

    R&C/CIC 1.0 0.9 1.0 1.0 1.0 1.0 4%

    PB 8.2 7.9 7.2 7.2 7.2 7.2 0%

    AM 1.8 1.6 1.6 1.5 1.4 1.4 -10%

    IB 12.8 11.3 10.7 10.2 9.9 9.9 -8%

    Centre 0.4 0.3 0.6 0.8 0.8 0.7 21%

    Total 23.3 21.2 20.0 19.6 19.2 19.2 -4%

    Staff cost by division

    CHF bn 2010 2011 2012e 2013e 2014e 2015e 2015e/2012

    WM 4.2 4.0 3.6 3.6 3.6 3.6 -1%

    R&C/CIC 0.6 0.6 0.6 0.6 0.6 0.6 6%

    PB 4.7 4.6 4.2 4.2 4.2 4.2 0%

    AM 1.1 0.9 1.0 0.9 0.9 0.9 -14%

    IB 8.0 6.7 6.3 6.0 5.8 5.8 -9%

    Centre 0.3 0.1 0.3 0.5 0.5 0.4 nm

    Total 18.9 16.9 16.1 15.8 15.5 15.5 -4%

    Implied loaded Cost per FTE

    CHFm 2010 2011 2012e 2013e 2014e 2015e 2015e/2012

    WM 0.36 0.34 0.32 0.32 0.32 0.32 2%

    R&C/CIC 0.19 0.19 0.19 0.20 0.20 0.20 4%

    AM 0.61 0.57 0.57 0.55 0.54 0.59 3%

    IB 0.64 0.55 0.51 0.51 0.50 0.51 -1%

    Centre 0.52 0.33 0.65 0.84 0.84 0.79 nm

    Total 0.46 0.43 0.41 0.41 0.41 0.41 0%

    Implied staff cost per FTE

    CHFm 2010 2011 2012e 2013e 2014e 2015e 2015e/2012

    WM 0.21 0.20 0.18 0.19 0.19 0.19 2%

    R&C/CIC 0.11 0.11 0.12 0.12 0.12 0.12 6%

    AM 0.36 0.33 0.36 0.34 0.33 0.36 -1%

    IB 0.40 0.32 0.31 0.30 0.29 0.30 -2%

    Centre 0.36 0.12 0.35 0.50 0.50 0.44 nm

    Total 0.39 0.34 0.33 0.33 0.33 0.33 1%

    Revenue

    CHFbn 2010 2011 2012e 2013e 2014e 2015e 2015e/2012

    WM 9.8 9.0 8.6 8.8 9.0 9.2 7%

    R&C/CIC 1.8 1.8 1.9 1.9 1.9 2.0 4%

    AM 2.3 2.1 1.9 2.0 2.0 2.0 8%

    IB 16.3 11.5 13.3 12.8 12.5 12.6 -6%

    Centre 0.2 0.0 0.0 0.1 0.1 0.1 nm

    Total 30.4 24.4 25.7 25.6 25.5 25.9 1%

    Implied Revenue per FTE

    CHFm 2010 2011 2012e 2013e 2014e 2015e 2015e/2012

    WM 0.49 0.44 0.44 0.46 0.47 0.48 11%

    R&C/CIC 0.36 0.36 0.39 0.40 0.39 0.40 4%

    AM 0.77 0.77 0.69 0.72 0.76 0.85 23%

    IB 0.81 0.55 0.64 0.64 0.64 0.65 1%

    Centre nm nm nm nm nm nm nm

    Total 0.62 0.49 0.52 0.54 0.54 0.55 6%

    Source: Liberum Capital

  • 7/30/2019 Equity Research: BUY case on UBS; HOLD CS

    17/47

    10 January 2013 Road to Damascus: Long Paul vs. Saul

    www.liberumcapital.com 17

    Relatively poor cost and RWA disclosure for CS

    In analysing the differences in costs and revenues between CS and UBS, its

    notable that CS doesnt provide staff costs (or RWA detail) for the WM and CIC

    divisions within private banking. We have estimated the numbers to facilitate the

    analysis.

    The IB divisions of both CS and UBS destroy economicvalue after fully loading divisions for cost savings,central costs, below the line items, and regulation

    In terms of presentation, both UBS and particularly CS flatter their divisionalresults by accumulating significant costs at the corporate centre and below

    the PBT line. Any meaningful sum of the parts (SoTP) valuation methodology

    has to allocate these centralised costs which are often at least partially ignored.

    In addition, a SoTP valuation should reflect the impact of regulation such asDodd Frank (negative for derivatives revenues as standardised derivatives move

    from relatively wide spread OTC trading to more transparent low margin

    exchange trading) and ring fencing (increased funding costs due to reduced

    implicit tax payer support) which will occur just beyond the explicitly

    forecasted earnings time horizon but clearly still impact valuation.

    In light of the above, we calculate 2013e fully adjusted divisional attributable

    earnings and RoB3E for UBS and CS.

    Since non equity minority interest charges relate to non equity regulatory capital,

    they are allocated in proportion to Basel 3 RWAs. We also allocate central costs in

    proportion to RWAs since these costs are largely proportional to balance sheet

    usage. We also allocate approximately half of the forecasted cost savings by 2015e

    to generate a more accurate normalised earnings run-rate for each division in

    2013e- effectively estimating a fully normalised 2014e run-rate for attributable

    earnings.

    As figure 26 illustrates, for UBS the capital adjusted Group return on Basel 3 equity

    (RoB3E) improves slightly to 22.4% on a fully loaded basis (due to cost savings)

    from 20.4% unloaded, however the divisional RoB3Es decline. The investment bank

    RoB3E declines to 5.5% (from 8.9%). On these numbers, shutting the UBS IB

    division entirely would be value accretive for UBS (about CHF3.3bn of fair value

    CHF0.9 per share before shutdown costs). However, arguably, profitability in the

    wealth management and R&C divisions probably depend to some extent on the IB

    depending on transfer pricing although UBS maintains all inter divisional

    transactions are arms-length implying UBS could realistically close its IB without

    impacting the earnings of its other divisions.

    Relatively poor disclosure on staff

    costs and RWAs from CS for the

    Corporate and Institutional division

    compared with UBSs for the Retail

    and Corporate division

    Both UBS and CS flatter their

    divisional RoB3Es by shiftingexpenses and RWAs to the

    corporate centre and by having

    expenses below the line such as

    preference share dividends and

    earnings for unvested equity.

    Shutting UBSs IB entirely would

    be value accretive by about

    CHF0.9 per share

  • 7/30/2019 Equity Research: BUY case on UBS; HOLD CS

    18/47

    10 January 2013 Road to Damascus: Long Paul vs. Saul

    18 www.liberumcapital.com

    Figure 26: UBS 2013e fully loaded divisional returns on Basel 3 equity at 10% Basel 3 equity gearing

    CHF bn YE13

    Basel 3RWAs

    Capital

    gearing

    Capital U/L PBT Attri b

    utableearnings

    Unloaded

    RoB3E

    Reallocate

    centrecapital

    Adjusted

    Allocatedcapital

    Reallocate

    centralcost,

    minoritiesetc

    Regulatory

    impact*

    Cost

    saves*

    Fully

    loadedattrib

    earnings

    Loaded

    RoB3E

    Wealth Mgmt 19.3 10% 1.9 2.8 2.2 112.1% 0.1 2.0 -0.1 0.0 0.1 2.2 107.8%

    Retail & Corporate 40.2 10% 4.0 1.8 1.4 34.7% 0.1 4.2 -0.3 0.0 0.1 1.2 28.3%

    GAM 3.6 10% 0.4 0.6 0.5 134.5% 0.0 0.4 0.0 0.0 0.0 0.5 123.1%

    Investment Bank 70.0 10% 7.00 0.8 0.6 8.9% 0.2 7.2 -0.5 -0.2 0.4 0.4 5.5%

    Wealth Mgmt USA 26.4 10% 2.6 1.1 0.9 32.7% 0.1 2.7 -0.2 0.0 0.0 0.7 24.9%

    Centre & MI** ex legacy 5.7 10% 0.6 -1.4 -1.1 -195.4% -0.6 - 1.1 0.0 0.0 0.0 nm

    Legacy runoff 60.8 10% 6.1 0.2 0.2 3.0% - 6.1 0.0 0.0 0.0 0.2 3.0%

    Subtotal 225.9 10% 22.6 5.9 4.6 20.4% 0.0 22.6 0.0 -0.2 0.6 5.1 22.4%

    Excess capital - 2.5 0.0 0.0 1.0% - 2.5 0 0 0 0.0 1.0%

    Total 225.9 25.1 5.9 4.6 18.4% - 25.1 0.0 -0.2 0.6 5.1 20.2%

    *Net tax ; **MI: Equity minorities interest chargeSource: Company Reports; Liberum Capital

    For CS, the fully loaded RoB3E declines to 13.0% vs. 13.8% as the regulatory

    impact of minus CHF0.5bn exceeds forecasted savings of CHF0.3bn.

    Figure 27: CS 2013e fully loaded divisional returns on Basel 3 equity at 10% Basel 3 equity gearing

    CHF bn YE13eBasel 3RWAs

    Capitalgearing

    AllocatedCapital

    U/LPBT

    Attrib utable

    earnings

    UnloadedRoB3E

    Reallocatecentrecapital

    AdjustedAllocated

    capital

    Reallocatecentral

    cost,minorities

    etc

    Regulatoryimpact*

    Costsaves*

    Fullyloaded

    attribearnings

    LoadedRoB3E

    Wealth Mgmt 24.0 10% 2.4 2.5 1.9 77.6% 0.1 2.5 -0.1 0.0 0.0 1.8 70.0%

    Corp and Institutions 48.7 10% 4.9 0.9 0.7 14.2% 0.2 5.1 -0.2 0.0 0.0 0.5 9.3%

    Asset management 12.6 10% 1.3 0.5 0.4 27.8% 0.1 1.3 0.0 0.0 0.1 0.4 28.7%

    Investment Bank 180.0 10% 18.0 2.6 2.0 10.9% 0.8 18.8 -0.71 -0.5 0.2 1.0 5.2%

    Centre & BTL** 12.0 10% 1.2 -1.2 -1.0 -86.8% -1.2 - 1.0 0.0 0.0 0 nm

    Subtotal 277.4 10% 27.7 5.2 3.8 13.8% 0.0 27.7 0.0 -0.5 0.3 3.6 13.0%

    Excess capital - 0.5 0.0 0.0 1.0% 0 0 0 0.0 1.0%

    Total 277.4 28.3 5.3 3.8 13.6% 0.0 -0.5 0.3 3.8 12.7%

    *Net tax; **BTL: Below the Line

    Source: Liberum Capital

    For CS, the loaded IB RoB3E of 5.2% implies the IB is destroying economic value.

    On these estimates, shutting Credit Suisses IB division would boost Group fair

    value by cCHF9.7bn (CHF6.1 per share). Net of shutdown costs we estimate

    restructuring or closing the IB could generate value in the range CHF 1.9-3.0 /share

    (8-15% of current share price)

    Basel 3 capital calculation YE13 (for valuation

    purposes): small surplus for both UBS and CS Libor risk: Our CS and UBS capital calculation used for valuation applies a

    CHF1.5bn capital deduction to reflect potential LIBOR fines (for CS, UBS has

    already incurred CHF1.4bn in fines and disgorgement) and litigation risk (both

    UBS and CS) although CS is on only 3 Libor setting panels (USD, CHF and

    EUR) and therefore is arguably less exposed than for example BARC which is on

    at least 10 of the major LIBOR panels.

    Our capital calculation implies a YE13e CHF2.5bn surplus for UBS andCHF0.5bn for CS relative to our assumed 10% imposed capital ratio target used

    for valuation.

    Although UBS will in reality will operate with a Basel 3 equity tier 1 in excess of13.0%, our valuation methodology assumes that the excess capital relative to

    On a fully attributed basis and after

    including future costs for regulatory

    changes and also future efficiency

    savings the implied IB RoB3E for

    UBS and CS are 5.5% and 5.2%

    respectively.

  • 7/30/2019 Equity Research: BUY case on UBS; HOLD CS

    19/47

    10 January 2013 Road to Damascus: Long Paul vs. Saul

    www.liberumcapital.com 19

    peers will be manifested in a lower cost of equity essentially viewing UBS as

    operating with excess capital equivalent of c3% of RWAs or approximately

    CHF6bn.

    Figure 28: YE13e Basel 3 equity position fully loadedCHF UBS CS

    Tier 1 capital 41.8 48.0

    Hybrids and Pref shares -4.3 -8.9

    Basel II Core Tier 1 (LIB Defn) 37.4 39.1

    Deduct Minorities 0 -3.2

    Include AFS reserves 0 0.0

    Deferred tax -4.8 -5.4

    Shortfall in provisions vs. exp. losses 0.0 0.0

    Pension -3.8 0.0

    Reverse securitis. deductions 50% 0.6 0.0

    Impact Libor fines/ litigation -1.5 -1.5

    Add back Basel 2 Fin Investments 0 0.0

    Other -2.9 -0.7

    B3 CET1 pre fin invest deductions 25.1 28.2Financial Investments 0 0

    Max recognisable Fin Investments 2.5 2.8

    Deduction of Fin Investments 0.0 0.0

    Basel III equity tier 1 25.1 28.2

    Basel 2.5 RWAs 163.3 239.6

    CVA RWA increase n/a 92.6

    Securitisation gross up n/a 0.0

    Mgmt mitigation n/a -55.0

    Basel III RWAs 225.9 277.2

    Basel II Core Tier 1 22.9% 16.3%

    Basel I II Equity T ier 1 inc luding Libor f ine and l it igat ion costs 11.1% 10.2%

    Bus mix required capital estimate 10.0% 10.0%

    Surplus capital 1.1% 0.2%

    Surplus 2.5 0.5

    Source: Company Reports; Liberum Capital

    SoTPs Valuation: 20% upside for UBS; 2% for CS

    UBSs increased capital discipline implies re-rating: UBSs clear intention tocapital ration its value-destroying IB division to a maximum of CHF70bn in RWAs

    increases the SoTP value of its other businesses in our view since more of the

    value created is likely to reach shareholders justifying our 14.0x multiple for

    Wealth Management and Asset Management earnings

    CSs ongoing IB ambitions imply a 12% PE multiple discount to 12.5x (vs. UBS14.0x) for the Wealth Management and Asset Management divisions given the

    likelihood/risk that free cash flow is diverted to the IB.

    Figure 29 shows the capital and regulation adjusted sum of the parts valuationfor UBS. The Attributable earnings are taken from figure 26 while the YE13e

    capital position is from Figure 28. The YE13e value per share is calculated and

    then discounted to the present (10 months). We also add the 2012e announced

    dividend paid in May 2013 as well as the announced 2013e dividend since its

    deducted from the YE13e capital position. All central and below the line earnings

    are allocated by division as well as capital held in the central division.

    The YE13e fully loaded basel 3

    capital level vs. a 10% target is a

    key input to our SoTPS valuation.

    We make a further adjustment to

    the fully loaded Basel 3 capital

    ratio of CHF1.5bn for both UBS

    and CS to reflect incremental costs

    related to Libor rigging both fines

    and litigation risk.

    UBS has lower risk of Wealth

    management and asset

    management cash flow being

    malinvested in the IB (due to

    smaller size and management

    commitment to a max of CHF70bn

    in IB RWAs). Therefore we

    assume UBSs WealthManagement and Asset

    Businesses merit a higher multiple

    of 14.0x in the SoTPs vs. 12.5x for

    CSs equivalent businesses.

  • 7/30/2019 Equity Research: BUY case on UBS; HOLD CS

    20/47

    10 January 2013 Road to Damascus: Long Paul vs. Saul

    20 www.liberumcapital.com

    For UBS we also apply a normalised tax rate of 22% (vs. the reported 15%or lower) and separately add the PV of UBSs unrecognised potential

    deferred tax assets see figure 34.

    Figure 29: UBS Sum of the Parts calculated at YE13e and discounted to present valueCHFbn Per Share

    YE13e Basel 3

    EquityCapital

    required

    Clean

    attributable earnings

    PE Clean

    YE13eValue

    Cost to

    achieve*

    Un-

    recognisedUPDTA

    YE13

    value

    PV Basel 3

    EquityCapital

    required

    Clean

    attributableearnings

    Clean

    YE13eValue

    Re-

    struccosts

    Un- recog-

    nised DTA

    Present

    Value/Share

    Wealth Mgmt Swiss 2.0 2.2 14.0 30.1 0.0 0.5 30.6 28.4 0.5 0.6 7.9 0.0 0.1 7.5

    Wealth Mgmt America 2.7 0.7 14.0 9.5 0.0 5.4 14.9 13.9 0.7 0.2 2.5 0.0 1.4 3.7

    Wealth Mgmt combined 4.7 2.8 14.0 39.5 0.0 5.9 45.5 42.3 1.2 0.7 10.4 0.0 1.6 11.1

    Retail & Corpor ate/ CIC 4.2 1.2 10.0 11.8 0.0 0 11.8 11.0 1.1 0.3 3.1 0.0 0.0 2.9

    Asset Management 0.4 0.5 14.0 6.4 0.0 0.0 6.4 6.0 0.1 0.1 1.7 0.0 0.0 1.6

    Investment Banking 7.2 0.4 9.0 3.6 0.0 1.6 5.2 4.8 1.9 0.1 1.0 0.0 0.4 1.3

    Core total 16.5 4.9 12.6 61.4 0.0 7.5 68.9 64.2 4.4 1.3 16.2 0.0 2.0 16.9

    Legacy 6.1 0.2 4.1 4.3 -3.5 0.0 0.7 0.7 1.6 0.0 1.1 -0.9 0.0 0.2

    Surplus/deficit (+/-) 2.5 0.0 2.5 0.0 2.5 2.3 0.7 0.0 0.7 0.0 0.0 0.6

    Total 25.1 5.1 13.4 68.2 -3.5 7.5 72.2 67.2 6.6 1.3 18.0 -0.9 2.0 17.7Dividends 12-13e 1.2 0.3

    Fair value 68.4 18.0

    Current market value 56.9 15.0

    Implied upside 20% 20%

    # shares bn 3.80

    Ke 9%

    time (years) 0.8

    Current share price 15.00

    *Cost to achieve: restructuring costs after YE13e and hence not reflected in YE13e equity capital

    Source: Liberum Capital

    UBS SoTPs value by division: the Wealth and asset management business willaccount for 68% of UBSs 2013e earnings and 75% of fair value in our SoTP

    (before considering unrecognised DTAs). The IB accounts for 32% of capital but

    only 5% of group value.

    CS SoTPs value by division: the Wealth Management businesses account for66% of value and 59% of earnings. The IB accounts for 68% of capital but only

    22% of value.

    Figure 30: Credit Suisse Sum of the Parts calculated at YE13e and discounted to present value

    CHF bn Per share

    YE13e Basel 3EquityCapital

    required

    Adjustedattributable

    earnings

    YE13ePE

    CleanYE13eValue

    Costs toachieve*

    YE13value

    PresentValue

    Basel 3EquityCapital

    required

    Adjustedattributable

    earnings

    PE CleanYE13eValue

    Coststo

    achieve

    YE13value

    PresentValue

    /Share

    Wealth Mgmt. 2.5 1.8 12.5x 22.0 0.0 21.9 20.4 1.6 1.10 12.5x 13.7 0.0 13.1 12.7

    Retail & Corp/ CIC 5.1 0.5 10.0x 4.7 -0.1 4.7 4.3 3.2 0.30 10.0x 3.0 0.0 3.2 2.7

    Asset Management 1.3 0.4 12.5x 4.7 0.0 4.7 4.4 0.8 0.24 12.5x 3.0 0.0 2.8 2.7

    Investment Banking 18.8 1.0 9.0x 8.9 -0.3 8.6 8.0 11.8 0.62 9.0x 5.5 -0.2 5.1 5.0

    Total core 27.7 3.6 11.2x 40.3 -0.4 39.9 37.0 17.3 2.25 11.2x 25.2 -0.2 24.2 23.2

    Surplus/deficit (+/-) 0.5 0.5 0.0 0.5 0.5 0.3 0.00 0.3 0.0 0.3 0.3

    Total 28.3 3.6 11.4x 40.9 -0.4 40.5 37.6 17.7 2.25 11.4x 25.6 -0.2 25.3 23.5

    Dividends 12-13e 2.4 1.5

    Fair Value 40.0 25.0

    Current Market value 39.0 24.4

    Implied upside 2% 2%

    # shares bn 1.60

    Ke 9%

    time (years) 0.8Current share price 24.4

    *Cost to achieve: restructuring costs after YE13e and hence not reflected in YE13e equity capital

    Source: Liberum Capital

    For UBS we include CHF2.0 per

    share of value for unrecognised

    potential deferred tax assets, whilenormalising the tax charge to 22%

  • 7/30/2019 Equity Research: BUY case on UBS; HOLD CS

    21/47

    10 January 2013 Road to Damascus: Long Paul vs. Saul

    www.liberumcapital.com 21

    UBS has a fair value per share of CHF18.0, 20% upside. CS has a fair valueper share of CHF25.0, 2% upside.

    PE multiples for selected WM peers: As a rough cross check for the 14.0x

    multiple applied to wealth management and asset management for UBS, figure31 shows the current PEx Julius Baer and Blackrock. While a highly limited

    sample, the current average multiple of 15.5x suggests our 14.0x multiple is not

    unreasonably high.

    Figure 31: Current PE multiples for Julius Baer and Blackrock

    10.00

    11.00

    12.00

    13.00

    14.00

    15.00

    16.00

    17.00

    18.00

    Jan-11

    Mar-11

    May-11

    Jul-11

    Sep-11

    Nov-11

    Jan-12

    Mar-12

    May-12

    Jul-12

    Sep-12

    Nov-12

    Jan-13

    BAER BLK Avg

    *PEx calculate using Bloomberg consensus for next 12 month Rolling EPS and grossing up by 4% to estimate current PESource: Bloomberg

    Wealth management peers trade

    on c15.5x current consensus

    earnings

  • 7/30/2019 Equity Research: BUY case on UBS; HOLD CS

    22/47

    10 January 2013 Road to Damascus: Long Paul vs. Saul

    22 www.liberumcapital.com

    BUY

    UBSAddition by SubtractionPRICE: 15.0 | SWITZERLAND | BANKS | UBSN.VX | UBSN VX

    In contrast to Credit Suisse, UBS has committed to radically

    downsizing its FICC business with cuts in IB RWAs of 57% and cuts

    in IB headcount of 42%. A dividend yield of 9.5-11.9% looks feasible

    2015-17e. Our Sum of the Parts implies 20% upside, with the WM

    businesses on a PE of 14.0x vs. WM peers on 15x. BUY.

    Improving cost efficiency: Analysis of costs per employee bydivision shows that UBS is on track to achieve a CHF3bn reduction in

    operating expenses by 2015e via headcount reduction of 10,000 of

    which we estimate 7,000 will be in the investment bank. On that basis

    we believe a Group cost income ratio of 72% is feasible by 2015 vs.

    81% in 2012e, and still above Managements target range of 60-70%.

    Significant capital release 9.5+% dividend yield by 2015e: FromYE12e-YE15e, UBS will reduce its Basel 3 RWAs by CHF 66bn

    releasing 8.6bn of capital (at a 13% equity ratio) while also achieving

    statutory earnings of CHF 10.1bn implying aggregate capital release

    of CHF18.7bn - equivalent to 33% of the current market cap. We

    expect UBS will exceed the 13.0% Basel 3 target by YE14e implying

    increased capital distributions from 2015 onwards- equiv. to a c9-10%

    yield while further increasing its Basel 3 equity to 15.8% by YE17e.

    Unrecognised Potential Deferred Tax Assets (UPDTAs) ofCHF24.6bn with an est. present value of CHF7.5bn equivalent to 13%

    of the current market cap. Our SoTPS assumes a normalised 22% tax

    rate and adds the CHF7.5bn separately (note: CS has no UPDTAs).

    UBSs 4Q12 profit warning offset by accelerated balance sheetshrinkage: The statement on 19

    thDec guided to a CHF2.0-2.5bn

    4Q12 attributable loss mainly due to Libor-rigging fines. However the

    Basel 3 equity capital ratio stayed at c9.3% implying a cCHF35bnshrinkage in RWAs thereby broadly offsetting the valuation impact and

    suggesting that UBS may reach the targeted CHF200bn of Basel 3

    RWAs well ahead of the YE17e guidance.

    UBS looks optically expensive on basic valuation metrics: 2013ePE 12.3x for p/TCE of 1.2x for RoTCE 10.9%; yielding 1.3% (UK

    banks PE only 10.6x).

    ..but UBS is cheap on an adjusted basis: Adjusted for capital,regulation, UPDTAs and ex legacy assets, UBS trades on 2013e PE

    10.0x; p/TCE 1.2x for RoTCE of 13.2% implying good relative

    value. Our capital and regulation adjusted SoTPs target price of

    CHF18.00 implies 20% upside. BUY.

    Stock Data

    Target Price (CHF) 18.00

    52-Week Range (CHF) 9.69 - 15.62

    Current price (CHF) 15.00

    Shares Outstanding (bn) 3.75

    Free Float (%) 91%Market Cap (CHF bn) 56.2

    Avg daily volume (m) 11

    *E=Liberum Capital Estimates

    Stock Performance

    7.0

    9.0

    11.0

    13.0

    15.0

    17.0

    Jan-12 Mar-12 Jun-12 Sep-12 Dec-12

    UBS EURO Banks

    Price Performance 1M 3M 12M

    Price 15.0 12.0 11.1

    Absolute 0% 25% 35%

    Rel SMI -2% 19% 18%

    Rel Eurobanks -6% 13% 1%Source: Bloomberg

    Summary Financials & Valuation

    Dec y/e (CHF bn) FY11A FY12E FY13E FY14ERevenue 29.8 25.6 27.5 27.4

    Op Costs -22.4 -27.7 -21.2 -20.3

    Impairments -0.1 -0.1 -0.1 -0.1

    PBT 7.3 -2.3 6.3 7.0

    Adj EPS, CHF 1.11 0.99 1.22 1.38

    P/Adj EPS 13.6 15.1 12.3 10.9

    DPS, CHF 0.1 0.2 0.2 0.5

    Yield % 0.7 1.0 1.3 3.3

    TCE/share, CHF 11.4 11.4 11.9 12.5

    RoTCE % 10.5% 8.7% 10.4% 11.3%

    P/TCE 1.31 1.31 1.26 1.20

    Basel 3 RWAs 380.0 266.0 225.9 210.9

    B3CET1* reportd (%) 10.7% 13.6% 17.8% 20.8%B3CET1* full load (%) 6.7% 9.3% 11.8% 13.6%Source: Liberum Capital estimates

  • 7/30/2019 Equity Research: BUY case on UBS; HOLD CS

    23/47

    10 January 2013 Road to Damascus: Long Paul vs. Saul

    www.liberumcapital.com 23

    UBSValuing UBS is relatively complex given that i) the group has a diverse group

    of businesses ii) is currently undergoing a radical restructuring iii) has hidden

    value due to Unrecognised Potential Deferred Tax Assets (UPDTAs).

    We address the business mix via a sum of the parts approach see main sectionFigure 29. i) The restructuring is outlined below followed by ii) our estimate of the

    present value of the UPDTAs iii) some comment on the 4Q12 profit warning

    related to the libor rigging fines and iv) some brief commentary on the divisional

    outlooks.

    i) Summary of UBS restructuring plans: shrinkingbalance sheet, capital consumption and headcount

    By way of background context, UBS plans to

    Shrink its group funded balance sheet by 30% to CHF600bn by YE15e.

    Reduce Basel 3 RWAs by 1/3rd

    : from CHF301bn to below CHF 250bn

    by YE13e and below CHF 200bn by YE17

    Reduce headcount by 10,000 to 54,000 (-16%) with majority of the cuts

    in the investment bank division. We estimate investment bank headcount

    will decline from 16,500 at YE12e to 9,500 by YE15e (-42%).

    Reduce operating costs by a further CHF4bn from the 9M12 annualised

    run rate, CHF2.5bn net of CHF1.5bn in planned increased investment. Our

    own forecasts assume net cost cuts of CHF3.0bn by YE15e to

    CHF19.5bn, a 13% decline, forecasting curtailed investment due to weaker

    than expected revenues- we are CHF1.1bn below consensus on 2015e

    revenues and 9% below consensus EPS.

    Exit FICC2

    businesses within credit and rates which are unlikely to beat

    their cost of capital under the new Basel 3 regulatory framework.

    As a consequence of this restructuring, UBS guides that the reported Group RoE will

    be in the 3-7% range in 2013 and 2014e implying annual 1-off restructuring costs of

    CHF3.5bn (assuming a c 5% reported RoE) relating to redundancy payments,

    losses on asset disposals etc. We factor this into our valuation (2013e impact

    included in YE13e capital and 2014/15 impact included in SoTPs separately net oftax).

    Smaller UBS balance sheet implies lower regulatory risk for UBS: The planned

    shrinkage of UBS funded balance sheet from CHF900bn to CHF600bn by 2015e

    will significantly reduce the valuation impact of any increase in RWA/Asset due to

    revised regulatory guidance on RWA calculation e.g. moving to standardised

    RWAs. This represents a key advantage vs. Credit Suisse in our view which will

    operate with CHF300bn of RWAs (vs. UBSs CHF200bn).

    UBS Cap-adjusted RoB3E rises to 26.0% by 2015e: As a consequence of these

    changes we estimate that by 2015e, adjusted for regulation and after allocating

    2 FICC: Fixed Income Currency and Commodities

    UBS has committed to closing

    many of its least profit IB

    businesses thereby boostingeconomic profit for Shareholders

    and more than doubling returns on

    regulatory equity capital

  • 7/30/2019 Equity Research: BUY case on UBS; HOLD CS

    24/47

    10 January 2013 Road to Damascus: Long Paul vs. Saul

    24 www.liberumcapital.com

    capital at 10% of Basel 3 RWAs, UBS will achieve an underlying return on Basel 3

    equity capital (RoB3E) of 26.0% up from 11.2% in 2012e; rising further to 30.3% in

    2017e due to further capital shrinkage under conservative operational leverage

    assumptions within the wealth management businesses.

    Of course on an actual reported basis returns will be more lacklustre due to the

    groups intention to operate at a 13% Basel 3 equity capital ratio, or higher, rather

    than the 10% gearing discussed above. In addition looking at profitability in terms of

    RoTCE further depresses returns due to several items included within equity (see

    figure 8). So the underlying RoTCE without adjusting for capital will increase

    only modestly from 8.7% in 2012e to 11.6% in 2017e.

    In our base case, by 2017e, UBS will have a Basel 3 equity capital ratio of15.8%, implying a CHF11.2bn capital surplus vs. our 10% requirement.

    Critical to our BUY investment case, is the assumption that equity investors will

    take account of UBSs excess capital in the valuation and will assess its capital

    position relative to international norms (we assume a 10% target) rather than

    relative to UBSs own 13% target capital run rate.

    The primary risk to our Buy case is the risk that UBS loses capital discipline onceit becomes highly cash-flow positive. We anticipate the tendency to expand the

    business via M&A or via RWAs credit growth will be considerable which could

    jeopardise our attractive dividend projections.

    For sake of comparison, UBSs restructuring of its IB is more radical thanthe substantial changes made by RBS with RWAs down -57% vs. 31% for

    RBS and Staff levels down 42% vs. 25% for RBS.

    Figure 32: RWAs Pre and Post IBrestructuring, reporting CCY bn

    Figure 33: IB Headcount Pre and Post IBrestructuring, 000s

    0

    50

    100

    150

    200

    RBS UBS

    Before After

    0

    5

    10

    15

    20

    RBS UBS

    Before After

    Source: Liberum , Company reports Source: Liberum , Company reports

    ii) Off balance sheet UPDTAs worth CHF7.5bnUBS has large Unrecognised Potential Deferred Tax Assets (UPDTAs) of

    CHF24.6bn (3Q12), 43% of market cap, generated as a result of net operating

    losses incurred during the 2007-2008 financial crisis. While not all of the UPDTAs

    are likely to be successfully utilised before expiration, we estimate that CHF 14.7bn,

    c60%, will be utilised. We estimate a present value for these of CHF7.5bn, or CHF2

    per share, equivalent to 13% of current market cap.

    Credit Suisse investor has no UPDTAs according to their investor relationsteam making this an often overlooked relative valuation factor in UBSs

    favour.

    UBSs IB restructuring is more

    aggressive than that of RBS

  • 7/30/2019 Equity Research: BUY case on UBS; HOLD CS

    25/47

    10 January 2013 Road to Damascus: Long Paul vs. Saul

    www.liberumcapital.com 25

    Under the IAS 12 accounting standards, deferred tax assets (DTAs) can only be

    recognised against probable future profits. UBS uses a 5 year time horizon for

    recognition. Without unrecognised DTAs, UBS would have a normalised tax rate in

    the range 20-25%. Our Sum of the parts assumes a 22% tax rate and then adds

    the CHF7.5bn present value of the UPDTAs. Over 2010 and 2011, recognisingmore DTAs enabled UBS to pay an average tax rate of only 6.1% resulting in a per

    annum boost to attributable earnings of c CHF1bn.

    Figure 34 summarises our valuation of the UPDTAs: In the US the averageremaining life of the CHF18.8bn of UPDTAs is 16 years as of 3Q12. We estimate

    the remaining life in Switzerland is 3 years (given a 7 year time limit and an

    assumed 2008 inception). In the UK there is no time limit on utilisation. We apply

    a relatively high discount rate in the US of 7.5% to reflect the constrained time

    limit. By contrast in the UK, with no time limit on utilisation we apply a discount

    rate of 3%. For the smaller RoW (rest of world) amounts of CHF 0.8bn we use a

    higher 10% discount rate to reflect lack of information/uncertainty.

    Figure 34: Estimating value of UBS Unrecognised Potential Deferred Tax Assets

    CHF bn Unrecognised potential

    DTAs

    Relevantannual PBT

    2014e

    Tax rate Annualrelevant

    payable tax

    EstimatedAmountutilisedbefore

    expiration

    Amountutilised preexpiration

    Est. date offull

    utilisation

    Remaininglife

    Assumeddiscount

    rate

    PV ofunrecognise

    d DTAs

    PV/ MaxPotential

    DTAs

    Value pershare

    US 18.8 1.4 35% 0.5 11.2 59% 2028 16 8% 5.1 27% 1.3

    Switzerland 2.4 4.8 20% 1.0 0.5 22% 2015 3 2% 0.5 21% 0.1

    UK 2.6 0.4 21% 0.1 2.63 101% 2039 Unlimited 3% 1.6 61% 0.4

    RoW 0.8 1 22% 0.2 0.4 50% 2020 n/a 10% 0.3 42% 0.1

    Total 24.6 7.6 23% 1.7 14.7 60% 7.5 31% 2.0

    Source: Liberum Capital

    By way of illustration we show the more detailed workings for the largest,CHF18.8n, of US Unrecognised Potential Deferred Tax Assets: Beyond the

    current 5 year measurement horizon which have already translated into on-

    balance sheet DTAs (albeit at conservative levels), we estimate US taxable

    earnings of CHF1.9bn (mainly from Wealth Management America but also the

    IB) from 2018e, growing at 4% per annum.

    In addition, prior to 2018e, we also consider the incremental PBT relative tothe current balance sheet DTA measurement assumptions. We understand

    from previous CFO guidance (John Cryan) that the DTA measurement process is

    highly conservative- taking substantial discounts to the actual management

    business plan. On that basis, we assume that there will be incremental US

    taxable annual earnings of CHF0.2-0.3bn within the current 5 year time horizon.

    Discounting all the savings at 7.5% gives us a present value of CHF5.8bn for the

    CHF18.8bn of US UPDTAs. An area of further investigation would be to what

    extent UBS could utilise more of these US UPDTAs by enhancing US taxable via

    M&A, incremental investment in its US franchise or other restructuring.

    Due to large historical losses UBS

    has more potential deferred tax

    assets than it can recognise under

    conservative accounting

    standards. We estimate a PV of

    CHF7.5bn for the off balance

    potential deferred tax assets

  • 7/30/2019 Equity Research: BUY case on UBS; HOLD CS

    26/47

    10 January 2013 Road to Damascus: Long Paul vs. Saul

    26 www.liberumcapital.com

    Figure 35: Estimating present value of Unrecognised potential DTAs in United States

    Years FWD Fin Yr Discount factor Assumed taxable earnings Tax saving PV @7% discount rate

    1 2013e 0.93 0.2 0.1 0.07

    2 2014e 0.87 0.3 0.1 0.09

    3 2015e 0.80 0.3 0.1 0.08

    4 2016e 0.75 0.3 0.1 0.085 2017e 0.70 0.3 0.1 0.07

    6 2018e 0.65 1.9 0.7 0.44

    7 2019e 0.60 2.1 0.7 0.44

    8 2020e 0.56 2.2 0.8 0.43

    9 2021e 0.52 2.4 0.8 0.43

    10 2022e 0.49 2.5 0.9 0.43

    11 2023e 0.45 2.7 1.0 0.43

    12 2024e 0.42 2.9 1.0 0.43

    13 2025e 0.39 3.1 1.1 0.42

    14 2026e 0.36 3.3 1.2 0.42

    15 2027e 0.34 3.6 1.2 0.42

    16 2028e 0.31 3.8 1.3 0.42

    Total utilised 32.0 11.2 5.1

    Unrecognised potential DTAs 18.8

    Assumed % utilised 59%

    Source: Company Reports; Liberum Capital

    iii) 4Q12 profit warning related to the Libor Riggingfines offset by higher than expected RWA shrinkage

    On 19Dec12, UBS announced an agreement to pay CHF1.4bn in fines anddisgorgement (of illegal profits) to US, UK and Swiss authorities. We

    estimate reported 4Q12 PBT of minus CHF2bn, as a result of this fine (not tax

    deductible) as well as other litigation provisions of CHF0.7bn, restructuring costs

    of CHF0.5bn as well as fair value own debt losses CHF0.4bn (due to tighteningcredit spreads).

    Excluding these items we estimate underlying 4Q12 PBT of positive CHF993mimplying an underlying adjusted EPS for full year 2012e of CHF0.99 after

    normalising the tax rate to 22% and excluding STAB option gains of CHF337m in

    9M12.

    Unchanged capital adequacy despite 4Q12 reported attributable loss ofCHF 2.25bn: The UBS statement referred to a roughly unchanged fully Basel 3

    equity tier 1 in 4Q12 vs. the reported 9.3% 3Q12 level. Assuming a 9.3% ratio at

    end 4Q12 which implies a significant 4Q12 drop in Basel 3 RWAs of CHF35bn.

    Accelerated restructuring: Based on the implied 4Q12 RWA shrinkage weexpect that UBSs balance sheet shrinkage will occur faster than 3Q12 guidance

    with positive implications for capital release and dividends

    iv) Group and Divisional P&L trends

    Underlying EPS trend: We expect 23% and 13% underlying EPS growth toCHF1.22 and CHF1.38 in 2013e and 2014e respectively primarily driven by

    strong PBT growth in the wealth and asset management divisions. We are 3%

    above Bloomberg adjusted consensus in 2014e- see figure 5- (however

    Bloomberg consensus has considerable noise with some estimates apparentlyincluding restructuring costs, where as we have excluded CHF3.5bn of 1-off

    costs in 2013e and 2014e from adj. EPS so its likely in our view that underlying

    consensus is considerably above the Bloomberg reported levels)

    To the extent UBS can boost its

    US pre tax earnings, it will be able

    to maximise its CHF18.8bn of US

    UPDTAs which we value currently

    at CHF5.1bn

    We estimate UBSs RWAs

    declined by CHF35bn in 4Q12

    which could indicate faster than

    expected capital release going

    forward.

  • 7/30/2019 Equity Research: BUY case on UBS; HOLD CS

    27/47

    10 January 2013 Road to Damascus: Long Paul vs. Saul

    www.liberumcapital.com 27

    Figure 36: UBS summary divisional PBT-underlying

    % Ch

    CHF bn 2011 2012e 2013e 2014e 2015e 2016e 2017e 2011 2012 2013 2014 2015 2016 2017

    Wealth Mgmt 2.3 2.3 2.8 3.0 3.1 3.3 3.5 -3% -2% 22% 8% 5% 6% 6%

    Retail & Commercial 1.7 1.6 1.8 1.8 1.8 1.8 1.7 -6% -3% 12% 0% -1% 0% -3%

    Global Asset Management 0.5 0.5 0.6 0.7 0.7 0.8 0.8 -12% 11% 24% 11% 6% 4% 4%Investment Bank 1.1 0.9 0.8 1.0 1.0 1.0 1.1 -49% -15% -15% 29% 0% 1% 1%

    Wealth Management USA 0.5 0.8 1.1 1.3 1.3 1.4 1.5 86% 75% 32% 14% 6% 6% 3%

    Centre Core -0.2 -0.9 -0.8 -0.7 -0.6 -0.5 -0.5 -12% -15% -17% -11% -11%

    Total Underlying PBT ex legacy 5.8 5.2 6.3 7.0 7.4 7.8 8.1 -19% -10% 20% 13% 5% 5% 4%

    Corporate centre legacy assets 0.0 0.0 -3.5 -3.5 -1.0 0.0 0.0

    Total U/L PBT 5.8 5.2 2.8 3.5 6.4 7.8 8.1 -19% -10% -47% 29% 81% 21% 4%

    1-offs -0.4 -7.5 0.0 0.0 0.0 0.0 0.0

    Reported PBT 5.4 -2.3 2.8 3.5 6.4 7.8 8.1

    Group MI s -0.3 -0.3 -0.3 -0.3 -0.3 -0.3 -0.3

    U/L Attributable 4.2 3.8 4.6 5.2 5.5 5.8 6.0

    EPS 1.11 0.99 1.22 1.38 1.45 1.53 1.59 -19% -11% 23% 13% 5% 5% 4%

    Basel 3 RWAs 380 266 226 211 200 192 195

    U/L Ro B3E at 10% CT1 11.2% 11.7% 18.8% 24.0% 26.9% 29.6% 31.2%

    Source: Liberum Capital

    At a group P&L level we expect broadly flat revenues in 2012-2014e withdeclines in investment banking revenues broadly offset by increases in the

    wealth and asset management divisions.

    Group expenses: We forecast a CHF3bn decline in expenses by 2015e vs.2012e slightly ahead of the guided net of CHF2.5bn (CHF4bn of reductions and

    CHF 1.5bn of investment spend) as we are relatively pessimistic on the revenue

    outlook vs. consensus and we suspect management plans.

    Figure 37: UBS Group P&L- underlying

    % Ch

    CHF bn 2011 2012e 2013e 2014e 2015e 2016e 2017e 2011 2012e 2013e 2014e 2015e 2016e 2017e

    Revenues 27.9 27.9 27.5 27.4 27.0 27.8 28.5 -10% 0% -1% 0% -1% 3% 3%

    Total expenses -22.0 -22.5 -21.2 -20.3 -19.5 -19.9 -20.4 -8% 2% -6% -4% -4% 2% 2%

    PIP 5.9 5.4 6.3 7.1 7.5 7.9 8.1 -18% -9% 18% 13% 5% 5% 4%

    Loan losses -0.1 -0.1 -0.1 -0.1 -0.1 -0.1 -0.1

    PBT (ex legacy) 5.8 5.2 6.3 7.0 7.4 7.8 8.1 -18% -10% 20% 13% 5% 5% 4%

    1.3 0.9 0.8

    Rev 1-offs 1.9 -2.3 0.0 0.0 0.0 0.0 0.0

    Cost 1-offs -0.4 -5.2 0.0 0.0 0.0 0.0 0.0

    1-offs 1.5 -7.5 0.0 0.0 0.0 0.0 0.0

    PBT (ex legacy) 7.3 -2.3 6.3 7.0 7.4 7.8 8.1

    U/L Attributable 4.2 3.8 4.6 5.3 5.5 5.8 6.0 -19% -11% 22% 13% 5% 5% 4%

    Cost Income 79% 81% 77% 74% 72% 72% 71%

    Basel 3 RWAs 380 266 226 211 200 192 195 0% -30% -15% -7% -5% -4% 1%

    U/L Ro B3E at 10% CT1 11.2% 11.7% 18.8% 24.0% 26.9% 29.6% 31.2%

    Source: Liberum Capital

    In wealth management we conservatively assume just 3.0% asset performancein 2013e (despite equity markets strong start YTD of 3-4%) and 2% in

    subsequent years (which includes reinvested dividends and coupons) and also

    conservatively assume net new money growth of only CHF25bn per annum (c3%

    of invested assets) down from CHF30bn in 2012e.

    We assume ongoing margin erosion down to 85bps vs. 2012e 90bps due to theongoing low yield environment and subdued client activity.

  • 7/30/2019 Equity Research: BUY case on UBS; HOLD CS

    28/47

    10 January 2013 Road to Damascus: Long Paul vs. Saul

    28 www.liberumcapital.com

    We assume relatively tight cost control with the cost income ratio towards thebottom end of managements guided range of 60-70%.

    Figure 38: UBS Wealth Management Division Underlying

    % Ch

    CHFbn 2011 2012e 2013e 2014e 2015e 2016e 2017e 2011 2012e 2013e 2014e 2015e 2016e 2017e

    Revenues 7.2 7.1 7.4 7.8 8.0 8.4 8.8 -2% -1% 4% 4% 4% 5% 5%

    Staff cost -3.3 -2.9 -2.9 -2.9 -3.0 -3.1 -3.3 3% -12% 1% 2% 3% 4% 4%

    Other expenses -1.6 -2.0 -1.8 -1.8 -1.9 -1.9 -2.0 -9% 22% -11% 2% 3% 4% 4%

    Total expenses -4.9 -4.8 -4.7 -4.8 -4.9 -5.1 -5.3 -2% -1% -4% 2% 3% 4% 4%

    PIP 2.3 2.3 2.8 3.0 3.1 3.3 3.5 -3% -2% 22% 8% 5% 6% 6%

    Loan losses 0.0 0.0 0.0 0.0 0.0 0.0 0.0

    Underlying PBT 2.3 2.3 2.8 3.0 3.1 3.3 3.5 -3% -2% 22% 8% 5% 6% 6%

    Rev 1-offs 0.4 0.0 0.0 0.0 0.0 0.0 0.0

    Cost 1-offs -0.1 0.2 0.0 0.0 0.0 0.0 0.0

    1-offs 0.4 0.2 0.0 0.0 0.0 0.0 0.0

    Reported PBT 2.7 2.5 2.8 3.0 3.1 3.3 3.5

    PAT 1.8 1.8 2.2 2.3 2.4 2.6 2.7

    Underlying attributable 1.7 1.6 2.0 2.1 2.2 2.4 2.5

    Net new Assets 24 30 25 25 26 26 26 -293% 27% -16% 1% 1% 1% 1%

    Performance -5.4% 6.7% 3.0% 2.0% 2.0% 2.0% 2.0%

    Invested Assets 750 830 880 923 967 1,012 1,058 -2% 11% 6% 5% 5% 5% 5%

    Margin (bps) 101 90 87 86 85 85 85

    Cost Income 68% 68% 63% 61% 61% 61% 60%

    Basel 3 RWAs 16.6 18.2 19.3 19.9 20.5 21.1 22.4

    PBT/Avg RWAs 14.0% 13.1% 14.8% 15.3% 15.5% 15.9% 16.1%

    U/L Ro B3E at 10% CT1 99% 93% 105% 108% 110% 113% 114%

    Source: Liberum Capital

    In Retail and corporate: we assume flat revenues and some declines in costs(due to restructuring programme) with the cost income ratio towards the low end

    of the guided 50-60% range.

    Figure 39: UBS Retail and Corporate Division Underlying

    % Ch

    CHFbn 2011 2012e 2013e 2014e 2015e 2016e 2017e 2011 2012e 2013e 2014e 2015e 2016e 2017e

    Revenues 3.9 3.7 3.7 3.7 3.7 3.7 3.7 -1% -4% 0% 0% 0% 0% 0%

    Staff cost -1.7 -1.4 -1.3 -1.3 -1.3 -1.3 -1.4 3% -18% -1% -1% 0% 0% 2%

    Other expenses -0.5 -0.8 -0.6 -0.6 -0.6 -0.6 -0.6 -1% 64% -24% 0% 0% 0% 3%

    Total expenses -2.1 -2.1 -1.9 -1.9 -1.9 -1.9 -2.0 2% -1% -9% -1% 0% 0% 2%

    PIP 1.8 1.6 1.8 1.8 1.8 1.8 1.7 -5% -8% 11% 0% -1% 0% -3%

    Loan losses -0.1 0.0 0.0 0.0 0.0 0.0 0.0

    Underlying PBT 1.7 1.6 1.8 1.8 1.8 1.8 1.7 -6% -3% 12% 0% -1% 0% -3%

    Rev 1-offs 0.3 0.0 0.0 0.0 0.0 0.0 0.0

    Cost 1-offs 0.0 0.2 0.0 0.0 0.0 0.0 0.0

    1-offs 0.3 0.2 0.0 0.0 0.0 0.0 0.0

    Reported PBT 1.9 1.8 1.8 1.8 1.8 1.8 1.7

    PAT 1.3 1.3 1.4 1.4 1.4 1.4 1.3

    Underlying attributable 1.2 1.1 1.3 1.3 1.3 1.3 1.2

    Invested assets 848 361 374 387 401 415 429

    Cost Income 55% 57% 51% 51% 52% 52% 53%

    Basel 3 RWAs 33.1 38.4 40.2 40.9 41.5 42.2 42.9

    PBT/Avg RWAs 4.9% 4.5% 4.6% 4.4% 4.3% 4.2% 4.1%

    U/L Ro B3E at 10% CT1 35% 32% 32% 31% 31% 30% 29%

    Source: Liberum Capital

    Asset Management:As in Wealth management we assume asset performanceof c2% per annum and some improvement in costs due to the restructuring

    bringing the cost income ratio towards the middle of the guided 60-70% range.

  • 7/30/2019 Equity Research: BUY case on UBS; HOLD CS

    29/47

    10 January 2013 Road to Damascus: Long Paul vs. Saul

    www.liberumcapital.com 29

    Figure 40: UBS Global Asset Management Division Underlying

    % Ch

    CHFbn 2011 2012e 2013e 2014e 2015e 2016e 2017e 2011 2012e 2013e 2014e 2015e 2016e 2017e

    Revenues 1.8 1.9 1.9 2.0 2.0 2.1 2.2 -12% 4% 4% 3% 3% 3% 3%

    Staff cost -1.0 -0.9 -0.9 -0.9 -0.9 -0.9 -0.9 -14% -5% -2% -1% 1% 2% 2%

    Other expenses -0.4 -0.5 -0.4 -0.4 -0.4 -0.4 -0.4 -9% 16% -7% -1% 1% 2% 2%Total expenses -1.3 -1.4 -1.3 -1.3 -1.3 -1.3 -1.4 -12% 1% -4% -1% 1% 2% 2%

    PIP 0.5 0.5 0.6 0.7 0.7 0.8 0.8 -12% 11% 24% 11% 6% 4% 4%

    Loan losses 0 0 0 0 0 0 0

    Underlying PBT 0.5 0.5 0.6 0.7 0.7 0.8 0.8 -12% 11% 24% 11% 6% 4% 4%

    Rev 1-offs 0.0 0.0 0.0 0.0 0.0 0.0 0.0

    Cost 1-offs 0.0 0.0 0.0 0.0 0.0 0.0 0.0

    1-offs 0.0 0.0 0.0 0.0 0.0 0.0 0.0

    Reported PBT 0.4 0.5 0.6 0.7 0.7 0.8 0.8

    PAT 0.4 0.4 0.5 0.5 0.6 0.6 0.6

    U/L Attributable 0.3 0.4 0.4 0.5 0.5 0.5 0.6

    Cost Income 75% 73% 68% 65% 64% 64% 63%

    Basel 3 RWAs 3.6 3.5 3.6 3.7 3.8 4.0 4.1

    PBT/Avg RWAs 12.8% 14.2% 17.5% 18.8% 19.4% 19.6% 19.9%

    U/L Ro B3E at 10% CT1 91% 100% 124% 134% 138% 139% 141% Source: Liberum Capital

    Investment Banking: We assume a sharp decline in FICC revenues cumulative 69% decline 2015e vs. 2012e as many credit and rates businesses

    are exited with CHF90bn (pre 4Q12 disposals) of RWAs assets transferred to the

    central legacy division to be run off. We assume equity revenues broadly flat

    with some steady improvement in M&A ECM and DCM from current relatively

    subdued levels.

    IB cost income ratio is forecast to decline to 83%: still towards the top end ofthe guided range of 65-85%, resulting in PBT achieved of c CHF1bn and RoB3Eof c10.5% before adjusting for Dodd Frank etc.

    We assume a CHF3.1bn or c69%

    decline in FICC revenues 2015 vs.

    2012

  • 7/30/2019 Equity Research: BUY case on UBS; HOLD CS

    30/47

    10 January 2013 Road to Damascus: Long Paul vs. Saul

    30 www.liberumcapital.com

    Figure 41: UBS Investment Banking Division Underlying

    % Ch

    CHFbn 2011 2012e 2013e 2014e 2015e 2016e 2017e 2011 2012e 2013e 2014e 2015e 2016e 2017e

    M&A ECM DCM 1.4 1.5 1.6 1.6 1.7 1.7 1.8 -43% 9% 4% 4% 4% 4% 4%

    Equities 3.7 3.1 3.1 3.2 3.2 3.2 3.2 -17% -17% 2% 2% 0% 0% 0%

    FICC 4.7 4.5 3.2 2.4 1.4 1.4 1.4 -4% -5% -28% -25% -42% 0% 0%Revenues 9.8 9.0 7.9 7.2 6.3 6.3 6.4 -17% -7% -12% -9% -13% 1% 1%

    Staff cost -5.6 -4.9 -4.3 -3.8 -3.2 -3.2 -3.2 -14% -12% -13% -12% -16% 1% 1%

    Other expenses -3.1 -3.2 -2.8 -2.4 -2.0 -2.0 -2.1 0% 4% -13% -15% -15% 1% 1%

    Total expenses -8.7 -8.1 -7.1 -6.2 -5.2 -5.2 -5.3 -9% -6% -13% -13% -16% 1% 1%

    PIP 1.1 0.9 0.8 1.1 1.1 1.1 1.1 -50% -16% -9% 30% 0% 1% 1%

    Loan losses 0.0 0.0 0.0 -0.1 -0.1 -0.1 -0.1

    U/L PBT 1.1 0.9 0.8 1.0 1.0 1.0 1.1 -49% -15% -15% 29% 0% 1% 1%

    Rev 1-offs IBD 0.00 0.0 0.00 0.00 0.00 0.00 0.00

    Rev 1-offs Equities -1.9 -0.4 0.00 0.00 0.00 0.00 0.00

    Rev 1-offs FICC -0.3 0.0 0.00 0.00 0.00 0.00 0.00

    Rev 1-offs -2.1 -0.4 0.00 0.00 0.00 0.00 0.00

    Costs 1-offs -0.2 -3.1 0.00 0.00 0.00 0.00 0.00

    FVOD 1.5 0.0 0.00 0.00 0.00 0.00 0.00

    1-offs -0.8 -3.5 0.00 0.00 0.00 0.00 0.00

    Reported PBT 0.3 -2.5 0.8 1.0 1.0 1.0 1.1 U/L PAT 0.9 0.7 0.6 0.8 0.8 0.8 0.8

    U/L Attributable 0.8 0.7 0.6 0.7 0.7 0.7 0.7

    Cost Income 89% 90% 89% 85% 83% 83% 83%

    Basel 3 RWAs 270.2 72.0 70.0 70.0 70.0 70.0 70.0

    Clean PBT/Avg RWAs 0.4% 0.6% 1.1% 1.5% 1.5% 1.5% 1.5%

    U/L Ro B3E at 10% CT1 2.8% 3.9% 8.0% 10.5% 10.4% 10.6% 10.7%

    Source: Liberum Capital

    Wealth Management Americas (WMA) division: We assume relatively goodrevenues and positive jaws vs. slower growing expenses in 2013e driving strong

    bottom line growth. Given the groups large but time-limited Unrecognised

    Potential DTAs in the the US, we would expect driving PBT growth in the WMA

    division to be a strategic imperative.

    Figure 42: UBS Wealth Management Americas Division Underlying

    % Ch

    CHFbn 2010 2011 2012e 2013e 2014e 2015e 2016e 2017e 2011 2012e 2013e 2014e 2015e 2016e 2017e

    Revenues 5.6 5.2 6.1 6.4 6.7 6.9 7.2 7.4 -6% 16% 6% 4% 4% 4% 4%

    Staff cost -4.2 -3.8 -4.3 -4.4 -4.5 -4.6 -4.7 -4.9 -9% 12% 2% 2% 3% 3% 4%

    Other expenses -1.1 -0.9 -1.0 -1.0 -1.0 -1.0 -1.0 -1.1 -15% 4% 1% 2% 3% 3% 3%

    Total expenses -5.3 -4.7 -5.2 -5.3 -5.4 -5.6 -5